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ABSTRACT 
This Scientific Report of EFSA provides scientific and technical assistance to the European Commission on (i) 
the minimum sample size to test, should an annual Bovine Spongiform Encephalopathy (BSE) statistical regime 
be authorised in healthy slaughtered cattle in certain EU Member States (MSs), and (ii) on the added value of 
that sample size for monitoring the trend of Classical BSE, Atypical BSE, and the emergence of a hypothetical 
new  type  of  cattle  Transmissible  Spongiform  Encephalopathy  (TSE).  Firstly,  an  evaluation  of  the 
epidemiological trends of BSE in 25 EU MSs was carried out in groups based on historical BSE monitoring data. 
Secondly,  and  with  the  aid  of  a  purpose-built  model  called  Cattle  TSE  Monitoring  Model  (C-TSEMM) 
developed  by  an  EFSA  contractor,  both  the  assessment  of  the  design  prevalence  and  of  the  sensitivity  of 
different BSE monitoring scenarios were carried out. Among the assumptions made in the C-TSEMM, a key one 
is  that  for  those  EU  MSs  with  no,  or  few,  BSE  cases  post-2001  an  alternative  estimate  of  cohort-based 
prevalence is required. This is estimated based on the average prevalence of the group of MSs with BSE cases 
under which they were placed in previous EFSA Opinions. Also, the model estimates presented are based on the 
demographics of the adult cattle population and on the number of adult cattle removed from the population via 
the  different  streams  in  2011  (i.e.  healthy  slaughter,  animals  showing  clinical  signs  of  disease  during  ante 
mortem inspection, emergency slaughtered animals and fallen stock). Therefore, future fluctuations in those 
numbers at EU level and in each of the MSs will impact on the validity of the estimates presented in this report. 
A series of recommendations are made on sampling strategies for BSE monitoring and on the future use of the 
C-TSEMM.   
© European Food Safety Authority, 2012 
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SUMMARY 
The European Commission has requested that the European Food Safety Authority (EFSA) provides 
scientific  and  technical  assistance  on  the  minimum  sample  size  to  test  should  an  annual  Bovine 
Spongiform Encephalopathy (BSE) statistical regime be authorised in healthy slaughtered cattle. In 
particular, in a scenario where the BSE testing of at-risk cattle would remain unchanged (i.e. testing of 
100 % of at-risk cattle over 48 months), EFSA was asked: (i) to propose a minimum annual sample 
size in healthy slaughtered cattle above 72 months of age, that would allow the detection of BSE with 
a yearly design prevalence of at least 1 case per 100 000 in the adult population (i.e. older than 24 
months of age) of the Member States (MSs), at a confidence level of 95% and both in the group of 25 
EU  MSs  that  are  entitled  for  having  the  BSE  monitoring  system  in  healthy  slaughtered  cattle 
reviewed
4 as a whole and in each Member State individually; and (ii) to advise on the added value of 
this minimum sample to the overall surveillance programme in terms of monitoring the trend of  
Classical BSE, Atypical BSE and the emergence of a hypothetical new type of cattle T ransmissible 
Spongiform Encephalopathy (TSE). 
Firstly, an evaluation of the epidemiolo gical trends of BSE in the 25 EU MSs is presented  in this 
report based on BSE monitoring data provided by the European Commission. For this purpose, MSs 
are grouped following a similar approach  taken in former EFSA Opinions: EU17 (Austria, Belgium, 
Cyprus,  Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg,  Netherlands, 
Portugal,  Slovenia,  Spain,  Sweden  and  United  Kingdom)  and  EU8  (Czech  Republic,  Estonia, 
Hungary, Latvia, Lithuania, Malta, Poland and Slovakia). The EU8 group of MSs is further subdivided 
in EU5 (Estonia, Hungary, Latvia, Lithuania and Malta), where BSE has not been detected and in EU3 
(Czech Republic, Poland and Slovakia), where BSE has been detected.  It is to be noted that unless 
otherwise specified, the term BSE  on its own refers to refers to all BSE types, including  Classical 
BSE, Atypical BSE and “Unknown” type of BSE (i.e. a reported BSE case that has not been typed). 
Based on that first evaluation, it was concluded that a constant decline in the total number of detected 
BSE cases (i.e. coming from both Active and Passive surveillance) has been recorded in the EU17 
group from 2 157 cases in 2001 to 27 cases in 2011.  In the EU3 group, the number of detected cases 
dropped down from 28 in 2005 (peak) to one in 2011. Moreover, the log10 transformed annual BSE 
prevalence and incidence (defined respectively as the number of positive BSE cases out of the tested 
population  and  out  of  the  standing  adult  cattle  population)  in  the  EU17  and  in  the  EU8  show  a 
statistically significant decreasing trend. There has been a statistically significant increasing trend in 
the average age of the detected BSE cases per test year during the last 11 years and eight years in the 
EU17 and the EU8, respectively. At present, this average age exceeds 11 years in each of these MSs 
(where reported in 2011). Furthermore, and assuming that the age distribution of cattle within the 
EU25 has not changed substantially, the decreasing trend observed in the annual BSE occurrence and 
the increasing  trend observed  in  the  annual  average  age  of  the  cases  are the  consequence  of  the 
implementation of the BSE control measures.  
Regarding Atypical BSE, it is concluded that epidemiological data reported by the EU MSs indicate 
that over the last years the number of detected did not show any trend and that these cases were mainly 
identified in the fallen stock and healthy slaughtered animals older than eight years of age. However, it 
is also noted that the performance of the current BSE monitoring system, both in terms of its analytical 
sensitivity and earliness of the detection of animals infected with Atypical BSE is unknown.  
Secondly, a model called Cattle TSE Monitoring Model (C-TSEMM) was developed by an EFSA 
contractor in order to provide a general frame for evaluating the design prevalence and the sensitivity 
                                                       
4   The EU 25 MSs are: Austria, Belgium, Czech Republic, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, 
Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Slovenia, Slovakia, Spain, 
Sweden and United Kingdom. Sample size healthy slaughter cattle BSE monitoring  
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of cattle TSE monitoring systems
5. The model was built considering available historical EU wide data 
on BSE monitoring, and contains assumptions, limitations and uncertainty that have to be considered 
when interpreting the different estimates that the model provides.  
Among those assumptions, a key one is that f or MSs with no ,  or few, BSE cases post -2001 an 
alternative estimate of cohort-based prevalence is required.  This has been estimated for those MSs 
based on the average prevalence of the group of MSs with BSE cases under which they were placed in 
previous EFSA Opinions
6: the EU17 or the EU8 group
7. This results in an overestimate of prevalence 
for countries with no recorded cases as they are assumed to be a m erged epidemiological unit with 
MSs where cases are observed. 
Based on the estimates provided by the C-TSEMM model (that considered prevalence in the standing 
adult cattle population (i.e. period prevalence in a given year of detectable infected animals in  the 
standing population) and the available historical EU wide data on BSE monitoring ), it can be 
concluded that in the EU25 as a whole the current BSE monitoring regime enables the detection of one 
BSE case in  6 354 930  adult cattle with a confidence level of 95%.  Moreover, if the current BSE 
monitoring regime would exclude testing of healthy slaughter cattle, it would be able to detect in the 
standing population one BSE case in 4 021 940 adult cattle with a confidence level of 95%. Therefore, 
no healthy slaughtered animals need to be tested in order to meet a design prevalence of  1 detectable 
case in 100 000 adult cattle, since testing of at risk animals (i.e. animals showing clinical signs during 
ante mortem inspection, emergency slaughter and fallen stock over 48 months of age and clinical 
suspects) is sufficient to meet the proposed design prevalence.  
Furthermore and also based on C-TSEMM model estimates, it can also be concluded that at individual 
MS level, in eight MSs (Belgium, Denmark, France, Germany, Ireland, Netherlands, Spain and the 
UK) the testing of healthy slaughter animals is not needed in order to meet a 1 in 100 000 design 
prevalence with a confidence level of 95%, since testing of at risk animals is sufficient to meet the 
proposed design prevalence. On the other hand, in four MSs (Austria, Italy, Poland and Sweden) the 
testing of a fraction of healthy slaughtered animals older than 72 months of age (i.e. on the basis of the 
number tested in 2011) would be sufficient to meet a 1 in 100 000 design prevalence with a confidence 
level of 95%. Finally, in thirteen MSs (Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, 
Latvia, Lithuania, Luxembourg, Malta, Portugal, Slovakia and Slovenia) the number of tested animals 
in 2011 (i.e. including all the healthy slaughtered animals older than 72 months of age) did not allow 
to meet a 1 in 100 000 design prevalence with 95% confidence. However, fitting a sample size larger 
than the actually slaughtered cattle population of a MS is neither feasible nor realistic. Thus, the 
current testing of all animals of certain age categories that are slaughtered or dead may provide the 
most sensitive BSE monitoring system possible (i.e. that employs post mortem tests) under the current 
epidemiological scenario with the potential limitation on the impact of the age at testing as evaluated 
in former related EFSA Opinions
8. 
                                                       
5  Amie  Adkin,  Robin  Simmons  and  Mark  Arnold;  Model  for  evaluation  of  different  options  for  the  monitoring  of 
Transmissible  Spongiform  Encephalopathies  in  cattle  in  the  European  Union  (C-TSEMM).  Supporting  Publications 
2012:EN-349. [55 pp.]. Available online: www.efsa.europa.eu/publications. 
6  Latest one: EFSA, 2010. Opinion of the Scientific Panel on Biological Hazards on a second update on the risk for human 
and animal health related to the revision of the BSE monitoring regime in some Member States. The EFSA Journal, 8(12), 
1946. 
7  EU17: Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, 
Portugal, Slovenia, Spain, Sweden and United Kingdom;  
    EU8: Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland and Slovakia 
8  EFSA (European Food Safety Authority), 2008a. Risk for Human and Animal Health related to the revision of the BSE 
Monitoring regime in some Member States. The EFSA Journal. 762, 1 - 47. 
  EFSA, 2008b. Further considerations of age-related parameters on the Risk for Human and Animal Health related to the 
revision of the BSE Monitoring regime in some Member States. The EFSA Journal, 763, 1-8. 
  EFSA, 2009. Updated risk for human and animal health related to the revision of the BSE monitoring regime in some 
Member States. The EFSA Journal, 1059, 1-40. 
  EFSA, 2010. Opinion of the Scientific Panel on Biological Hazards on a second update on the risk for human and animal 
health related to the revision of the BSE monitoring regime in some Member States. The EFSA Journal, 8(12), 1946. Sample size healthy slaughter cattle BSE monitoring  
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It is further concluded that in the event of a re-emergence of Classical BSE, stopping the testing of 
healthy slaughtered cattle would lower the sensitivity of its detection by the TSE monitoring system. 
As an example, based on a theoretical scenario of an annual 10% increase in detectable cases in the 
tested population (prevalence), the C-TSEMM model estimates that: (i) In the EU25 as a whole, where 
testing healthy slaughtered cattle above and age of 72 months is not needed in order to meet the 
proposed design prevalence, the time to detection of the supposed 10% yearly increase in detectable 
cases would increase from six to 11 years ( i.e. five extra years to detect the supposed 10% yearly 
increase in prevalence of detectable cases) should testing of healthy slaughtered cattle be stopped 
compared to the current testing regime; (ii) In those MSs where testing healthy slaughtered cattle 
above the age of 72 months is not needed in order to meet the proposed design prevalence (Belgium, 
Denmark, France, Germany, France, Ireland, Netherlands, Spain and the UK), it would take between 
three and eight extra years (depending on the MS) to detect that yearly increase in prevalence should 
testing of healthy slaughtered cattle be stopped compared to the current testing regime; (iii) In those 
MSs where testing healthy slaughtered cattle could be reduced in order to meet the proposed design 
prevalence  (Austria,  Italy,  Poland  and  Sweden),  it  would  take  between  six  and  16  extra  years 
(depending  on  the  MS)  to  detect  that  yearly  increase  in  prevalence  should  testing  of  healthy 
slaughtered cattle older than 72 months of age be reduced to the number needed to meet the proposed 
design prevalence compared to the current testing regime; (iv) In those MSs where testing healthy 
slaughtered cattle  older than  72  months  of  age  as per  the  current  BSE  monitoring  regime  is  not 
sufficient to meet the proposed design prevalence(Cyprus, Czech Republic, Estonia, Finland, Greece, 
Hungary,  Latvia,  Lithuania,  Luxembourg,  Malta,  Portugal,  Slovakia  and  Slovenia),  it  would  take 
between three and 25 extra years (depending on the MS) to detect that yearly increase in prevalence 
should testing of healthy slaughtered cattle be stopped compared to the current testing regime.  
When considering Atypical BSE, at EU25 as a whole there is not sufficient data (i.e. number of 
detected  cases  annually)  to  reliably  estimate  with  the  C-TSEMM  model  the  impact  of  the 
stopping/continuation of testing healthy slaughtered animals older than 72 months. However, when 
using France as an example (i.e. country with a large population and sufficient number of detected 
Atypical cases) the C-TSEMM model indicates that, based on a theoretical scenario of an annual 10% 
increase of detectable prevalence of Atypical BSE in the tested population, it would take an extra 13 
years  to  detect  that  yearly  increase  in  prevalence  should  testing  of  healthy  slaughtered  cattle  be 
stopped compared to the current testing regime. 
Considering the timeframe available for this mandate, carrying out simulation studies for hypothetical 
new types of cattle TSEs was not possible. However, it was concluded that the C-TSEMM model can 
be  considered  as  a  useful  tool  in  order  to  simulate  future  ad  hoc  epidemiological  scenarios  of 
hypothetical new types of cattle TSEs. 
It  is  highlighted  that  when  interpreting  the  estimates  presented  above  or  those  obtained  in  future 
simulations performed with the C-TSEMM model, consideration has to be given to the assumptions, 
limitations and uncertainty in the model. Moreover, the models estimates presented in this report are 
based on the demographics of the adult cattle population in 2011 and on the number of adult cattle 
removed from the population via the different streams (i.e. healthy slaughter, animals showing clinical 
signs of disease during ante mortem inspection, emergency slaughtered animals and fallen stock). 
Therefore, future fluctuations in those numbers at EU level and in each MSs will impact the validity of 
current estimates. 
A series of recommendations are made in this report including considerations on the sampling strategy 
should monitoring of BSE in healthy slaughtered cattle remain based on a sample of animals over 
certain age, and considerations on future potential needs for the assessment of the impact of changes to 
current EU BSE control measures in the sensitivity of the EU surveillance system.  
It is finally recommended that if the C-TSEMM model will be employed in future years for the review 
of the BSE monitoring regime in the EU, updated yearly data including BSE testing data have to be 
considered as these drive the results estimated by the model. Sample size healthy slaughter cattle BSE monitoring  
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
According to TSE legislation
9, each Member State shall carry out an annual monitoring programme 
for BSE, including a screening procedure using rapid tests approved for that purpose. This programme 
shall cover, as a minimum, a ll bovine animals above 30 months of age slaughtered normally for 
human consumption (healthy slaughtered cattle) and all bovine animals above 24 months of age which 
have died/been killed or been sent for emergency slaughter (at risk cattle). However, a Mem ber State 
which can demonstrate, based on epidemiological criteria, the improvement of the BSE situation on its 
territory may send an application to the Commission with a view to being authorised to revise its 
monitoring programme. 
Since 2009, all Member S tates except Bulgaria and Romania have progressively been authorised, 
based on their favourable epidemiological situation and following positive EFSA opinions
10, to review 
their BSE monitoring programmes and to raise the age limit for testing to 72 months i n healthy 
slaughtered cattle and 48 months in at risk cattle. 
Furthermore, as laid down in Article 2, point 3 of Commission Decision 2009/719/EC as amended  by 
Commission Implementing Decision 2011/358/EU
11, these 25 Member States will be allowed, as from 
1st January 2013, to test only a minimum annual sample of the healthy slaughtered cattle above 72 
months of age. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Article 31 of (EC) Regulation 178/2002, EFSA is requested to provide scientific 
and technical assistance on the minimum sample size that the Member States that are listed in the 
Annex to Commission Decision 2009/719 as lastly amended by Commission Implementing Decision 
2011/358/EU should test for BSE as from 1st January 2013, if they decide to opt after that date for 
testing only a minimum annual sample of the healthy slaughtered cattle population. 
More specifically, in a scenario where the BSE testing of at-risk cattle would remain unchanged (i.e. 
testing of 100 % of at-risk cattle over 48 months), EFSA is asked to propose a minimum annual 
sample size in healthy slaughtered cattle above 72 months of age in order to: 
-  allow the detection of BSE (both  Classical and Atypical strains) with a design prevalence of 
at least one case per 100 000 in the adult population of the Member States, at a confidence 
level of 95% (i.e. consistent with type A surveillance as described in article 11.5.22 of the OIE 
code); 
-  monitor the trend of BSE in cattle (both  Classical and Atypical strains); 
-  detect the emergence of a hypothetical new type of TSE in cattle. 
                                                       
9   Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the 
prevention, control and eradication of certain transmissible spongiform encephalopathies (OJ L 147, 31.5.2001, p. 1) 
10   17 July 2008: „Scientific Opinion of the Panel on Biological Hazards on a request from the European Commission on the 
risk for human and animal health related to the revision of the BSE monitoring regime in some Member States‟, The 
EFSA Journal (2008) 762, p. 1. 
  29 April 2009: „Scientific Opinion of the Panel on Biological Hazards on a request from the European Commission on 
the updated risk for human and animal health related to the revision of the BSE monitoring regime in some Member 
States‟, The EFSA Journal (2009) 1059, p. 1. 
  December 2010: "Scientific Opinion on a second update on the risk for human and animal health related to the revision of 
the BSE monitoring regime in some Member States", The EFSA Journal 2010; 8(12):1946 
     April 2011: "Scientific Opinion on the review on the risk for human and animal health related to the revision of the BSE 
monitoring regime in three EU Member States", The EFSA Journal 2011;9(4):2142 
11   Commission Implementing Decision 2011/358/EU of 17 June 2011 amending Decision 2009/719/EC authorising certain 
Member States to revise their annual BSE monitoring programmes (OJ L161, 21.6.2011, p.29) Sample size healthy slaughter cattle BSE monitoring  
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In order to facilitate implementation by the Member States, according to their adult cattle population 
(>2 years of age - see Table 1), the sample size should be determined for each of the following adult 
cattle population groups: <25 000; [25 000 – 50 000]; [50 000 – 100 000]; [100 000 – 200 000];     
[200 000 – 300 000]; [300 000 – 400 000]; [400 000 – 500 000]; [500 000 – 600 000]; [600 000 – 700 
000]; [700 000 – 800 000]; [800 000 – 900 000]; [900 000 – 1 000 000]; ≥ 1 000 000. 
The adult cattle population (>2 years of age) of the 25 Member States and an estimate of the 
number of cattle over 72 months old is provided in Table 1. 
Table 1:   Distribution of the adult cattle population in the 25 EU Member States. 
Proposed adult cattle 
population group 
(>24 months) 
Member State  Adult cattle population  
(>24 months)
12 
Estimate of healthy cattle 
>72  months  slaughtered  
each year
13 
<25 000  Malta      7 200       635 
  Cyprus    24 800    2 683 
[25 000 – 50 000]        
[50 000 – 100 000]  Luxembourg    98 400    4 747 
[100 000 – 200 000]  Estonia  125 900  10 804 
[200 000 – 300 000]  Slovenia  201 000  14 384 
Latvia  206 300  20 145 
Slovakia  241 000  14 946 
[300 000 – 400 000]  Hungary  357 000  33 048 
Greece  361 000  15 072 
Finland  380 200  31 202 
[400 000 – 500 000]  Lithuania  420 000  49 078 
[500 000 – 600 000]        
[600 000 – 700 000]  Czech Republic  628 600  52 511 
Sweden  650 500  53 717 
[700 000 – 800 000]  Denmark  760 000  67 315 
[800 000 – 900 000]  Portugal  810 200  62 016 
[900 000 – 1 000 000]  Austria  935 600  118 175 
≥ 1 000 000  Belgium  1 321 500  116 551 
Netherlands  1 766 000  197 673 
Italy  2 704 300  281 190 
Poland  2 948 300  335 689 
Ireland  2 957 400  292 424 
Spain  3 258 200  299 737 
United Kingdom  4 652 000  476 697 
Germany  5 822 600  606 562 
France  10 544 000  1 087 646 
 
 
 
 
                                                       
12   Source: EUROSTAT July 2011 
13   Source: Number of healthy slaughtered cattle over 72 months tested in 2010 (TSE database) Sample size healthy slaughter cattle BSE monitoring  
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Clarification on the Terms of Reference: 
Following discussions with the European Commission, the above Terms of Reference were rephrased 
as follows: 
More specifically, in a scenario where the BSE testing of at-risk cattle would remain unchanged (i.e. 
testing of 100 % of at-risk cattle over 48 months): 
-  EFSA is asked to propose a minimum annual sample size in healthy slaughtered cattle above 
72 months of age in order to allow the detection of BSE with a yearly design prevalence of at 
least one case per 100 000 in the adult population of the Member States, at a confidence level 
of  95%  in  the  group  of  25  EU  Member  States  as  a  whole  and  in  each  Member  State 
individually; 
-  What is the added value of this minimum sample to the overall surveillance programme in 
terms  of  monitoring  the  trend  of  Classical  BSE,  Atypical  BSE  and  the  emergence  of  a 
hypothetical new type of cattle TSE? 
 Sample size healthy slaughter cattle BSE monitoring  
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ANALYSIS 
1.  Introduction 
The current Active monitoring of cattle TSEs in the European Union (EU) has been traditionally 
designed  with the aim  of  ensuring  that  all  bovines  of  certain  age  are  tested.  The  age  for  testing 
depends on the health status of the animal (i.e. healthy slaughtered animals, emergency slaughtered, 
animals showing clinical signs during ante mortem inspection, fallen stock)
14.  
In view of the BSE epidemiological trends in the EU, the European Commission has tasked in the past 
to EFSA the assessment of the age for TSE testing of cattle in some EU Member States (MSs) (EFSA, 
2008a, 2008b, 2009, 2010, 2011). As a consequence, a derogation allows 25 EU MSs
15 to test healthy 
slaughtered cattle at 72 months and at risk cattle at 48 months of age. Nevertheless, MSs may continue 
testing at younger ages. Table 2 shows the age for testing BSE in cattle in the EU implemented by the 
MSs in 2011. 
Table 2:   BSE testing ages (in months) for bovine animals during 2011 in the EU MSs by testing 
stream. When the same testing age applies to different testing streams this is shown overarching those 
streams. Source: European Commission. 
  Age limit in months 
  Fallen 
Stock 
Emergency 
slaughtered 
Clinical 
signs at AM 
Healthy 
slaughtered 
BSE 
eradication 
BSE 
suspects 
Austria  > 24  > 48  > 72*  No age limit 
Belgium  > 48  > 72*  > 24  No age limit 
Bulgaria  > 24  > 30  No age limit 
Czech Republic  > 48*  > 72*  No age limit 
Cyprus*  > 24  > 72*  > 48  No age limit 
Denmark  > 48  > 72*  > 24  No age limit 
Estonia  > 48*  > 72*  No age limit 
Finland  > 48  > 72*  No age limit 
France  > 24  > 72*  > 24  No age limit 
Germany  > 48  > 72*  No age limit 
Greece  > 48  > 72*  No age limit 
Hungary  > 24  > 72*  No age limit 
Ireland  > 48  > 72*    No age limit 
Italy  > 48  > 72*  No age limit 
Latvia  > 48*  > 72*  No age limit 
Lithuania  > 48*  > 72*  No age limit 
Luxembourg  > 24  > 48  > 72*  > 24  No age limit 
Malta  > 48*  > 72*  No age limit 
Netherlands  > 48  > 72*  No age limit 
Poland  > 48*  > 72*  No age limit 
Portugal  > 48*  > 72*  >48*  No age limit 
Romania  > 24  > 30  No age limit 
Slovakia  > 48*  > 72*  No age limit 
Slovenia  > 48  > 72*  No age limit 
Spain  > 36  > 72*  No age limit 
Sweden  > 48  > 72*  No age limit 
United Kingdom  > 48  > 72*  No age limit 
* Since 1 July 2011 
                                                       
14   As defined in Annex III, Chapter A of Reg. (EC) 999/2001 (as amended) of the European Parliament and of the Council 
of  22  May  2001  laying  down  rules  for  the  prevention,  control  and  eradication  of  certain  transmissible  spongiform 
encephalopathies (OJ L 147, 31.5.2001, p. 1). 
15   At  present  Bulgaria and Romania have not been yet considered for an increase in testing ages due to the six -year 
requirement of EU BSE monitoring and controls been fully implemented.  Sample size healthy slaughter cattle BSE monitoring  
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This Scientific Report of EFSA replies to the request of the European Commission that seeks advice 
on a minimum annual sample size in healthy slaughtered cattle above 72 months of age (i.e. move 
from  systematic  testing  to  annual  sample-size  testing)  whereby  testing  of  at-risk  cattle  would  be 
maintained at 48 months of age (i.e. unchanged with current practices). This minimum annual sample 
size of healthy slaughtered cattle: 
  Should allow the detection of BSE with a yearly design prevalence of at least one case per 100 
000 in the adult cattle population of the MSs at a confidence level of 95% (it should be taken 
into account that testing of all the at risk cattle over 48 months of age also counts when 
meeting that design prevalence), 
  Has to be examined for its added value to the overall surveillance programme for monitoring 
the trend of  Classical BSE, Atypical BSE and the emergence of a hypothetical new type of 
cattle BSE. 
2.  Analysis of the trend of BSE in the 25 EU Member States 
2.1.  Approach, data sources and general assumptions 
For the purposes of the review of the BSE monitoring regime in the 25 EU MSs considered in this 
Report, EU MSs are separated into two groups based on BSE monitoring data, resulting in: 
  A group of 17 EU MSs (hereafter referred as EU17), for which the data taken into account 
goes  back  to 1
st January  2001  (i.e.  consistent  with the approach  taken in previous  EFSA 
Opinions). The EU MSs forming this group are: Austria, Belgium, Cyprus, Denmark, Finland, 
France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal, Slovenia, Spain, 
Sweden and United Kingdom.   
  A group of 8 EU MSs (hereafter referred as EU8), for which data taken into account goes back 
to 1
st January 2004
16 (i.e. consistent with the approach taken in previous EFSA Opinions). The 
EU MSs forming this group are: Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, 
Poland and Slovakia. Within this group, two subgroups are identified: A subgroup of 5 EU 
MSs (hereafter referred as EU5) where BSE has not been reported (i.e. Estonia, Hungary, 
Latvia, Lithuania and Malta) and a subgroup of 3 EU MSs (hereafter referred as EU3) where 
BSE has been reported (i.e. Czech Republic, Poland and Slovakia). 
The following data sources have been employed for the analysis presented in this Report: 
  Data on BSE cases detected in the EU were received from the European Commission on 3 
July 2012. Further clarifications on these data were made with the support of the European 
Commission. The following has to be taken into account when interpreting the data presented 
in this Scientific/Technical Report: 
o  Unless otherwise specified, the term “BSE” on its own refers to all BSE types, including  
Classical BSE, Atypical BSE and Unknown type of BSE (i.e. a reported BSE case present 
in the data received from the European Commission that has not been typed).  
o  Only reported BSE cases with known age category (i.e. age-group reported in the database 
from the European Commission) and year of testing are considered. Based on this, a total 
of 15 reported cases were excluded from the analysis, as described in Appendices A and 
B.  
  Data on the number of rapid TSE tests performed in the EU in the frame of BSE monitoring 
                                                       
16   When applicable, the number of BSE cases diagnosed before 1
st May 2004 in the MSs of the EU8 group are addressed in 
the relevant tables in Appendix A. Sample size healthy slaughter cattle BSE monitoring  
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were received from the European Commission (EC) on 11 January 2012 and 3 July 2012. 
When  needed,  clarifications  on  these  data  were  made  with  the  support  of  the  European 
Commission. 
  Data on the adult bovine population (over 24 months of age) from the year  2011 in the 25 
MSs  were  received  from  the  European  Commission  on  11  January  2012,  and  were  also 
retrieved from EUROSTAT
17 on 5 and 26 April 2012 for the whole period 2001 to 2011. 
Detailed epidemiological information on BSE monitoring in the EU  can be found in the TSE annual 
reports released by the EC, available at: 
http://ec.europa.eu/food/food/biosafety/tse_bse/monitoring_annual_reports_en.htm 
Summary tables reviewing the trend of BSE in the EU 25 MSs grouped in EU17 and EU8 are 
presented in Appendix A. The number of BSE cases detected through the BSE surveillance (Active 
and Passive) between 2001 /2004  and 2011 per  EU  MS, birth cohort and year of detection are 
presented in Appendix B. 
Some minor differences may be found between the data present ed in this EFSA Report and those 
presented in previous EFSA Opinions. This is due to ongoing updates/corrections that the MSs may 
make to the European Commission databases on BSE monitoring and to EUROSTAT databases. On 
the other hand, the few BSE cases arising from BSE eradication measures (i.e. cohort-culling) are not 
included in the calculations presented in section 2 of this Report, as they come from a stream other 
than the epidemiological surveillance. However, it has to be noted that their exclusion d oes not affect 
the trends of the BSE epidemic.   Details on the number of these cases per MS are presented in 
Appendix B. 
In line with previous EFSA Opinions dealing with requests on the BSE monitoring regime (EFSA, 
2008a, 2008b and 2009), three key assumptions are made for each EU MS considered in this Report in 
order to render the analysis presented in this chapter valid: 
  It  is  assumed  that all  25 EU  MSs  considered  for this  mandate  have  implemented  a  BSE 
surveillance system and control measures as set out in Reg. (EC) 999/2001
18 for at least six 
years. If this assumption cannot be verified, the conclusions of this opinion will not apply to 
the respective MS. 
  It is assumed that all 25 EU MSs considered for this mandate will continue to implement 
currently applied measures as set out in Reg. (EC) 999/2001 aimed at controlling and reducing 
BSE in the EU MSs.  
  It is assumed that the rapid tests applied in the frame of the Reg. (EC) 999/2001 for BSE 
surveillance have a sensitivity of 100% in the very late stages of the incubation period. The 
likely point in the incubation period at which PrP
res is detectable with the rapid BSE tests 
depends on the infective dose. While the range of doses of exposure of field cases of BSE is 
not known, an oral attack rate study has shown that the mean incubation period arising from 
doses in the range 0.1-1g fits with that estimated for field cases. For a 1g dose, it was found 
that PrP
res was detectable only after 97% of the length of the incubation period. This degree of 
under-detection  has  to  be  taken  into  account  when  estimating  infection  prevalence  from 
surveillance data.  
                                                       
17     EUROSTAT data available at: http://epp.eurostat.ec.europa.eu/portal/page/portal/eurostat/home – Data tree: Statistics> 
Data Navigation Tree> Database by themes>  Agriculture, forestry and fisheries> Food: From farm to fork statistics 
(food) > inputs to the food chain (food_in)> Livestock (1000 heads) (food_in_pagr2) 
18   Regulation (EC) 999/2001 of the European Parliament and of the Council laying down rules for the prevention, control 
and eradication of certain transmissible spongiform encephalopathies. Sample size healthy slaughter cattle BSE monitoring  
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When interpreting the significance of the results presented in this section of the EFSA report, the 
following points should also be considered: 
  The shape of the age distribution of BSE cases depends on two aspects: the age distribution of 
the cattle population and the level of BSE transmission in the past (de Koeijer et al., 2002). 
  Out of the BSE cases found in the EU17, only 47 cases were related to animals born after the 
start of the total feed ban in 2001. 
  The EU8 are all new EU MSs since 1 May 2004, since when the EU total feed ban has been 
implemented in these MSs. In the EU3 a total of 16 cases have been born since 2001, and 3 
cases are born after 30
th April 2004. 
  The Geographical BSE Risk as well as the stage of the BSE epidemic can vary considerably 
between MSs. 
Furthermore, this Scientific Report is supported by the modelling work of a contractor (Animal Health 
and Veterinary Laboratories Agency (AHVLA), United Kingdom) identified by EFSA through an 
open call for tender (Ref. CT/EFSA/BIOHAZ/2011/03
19). Key background details and results of the 
modelling work are presented in section 5 of this EFSA Report. Also,   the full Scientific Report 
submitted to EFSA by the contractor (Adkin et al., 2012) should be read as background and supporting 
information. 
2.2.  Trends of BSE in the EU17 during the period 2001 to 2011 
Extensive  epidemiological  data  on  BSE  has  been  collected  via  the  BSE  Active  and  Passive 
Surveillance over the last 11 years in the EU17. Detailed tables on the epidemiological trend of BSE 
are presented in Appendix A, while in this section summary tables and figures are presented. 
From 2001 until the end of 2011, more than 92 million of tests were carried out in the framework of 
BSE Active Surveillance in the EU17. Of these, 5 220 animals were positive. These included 1 266 
out of 79 277 027 million healthy slaughtered cattle tested (15.96 per million healthy cattle tested), 
and 3 954 out of 13 055 343 at risk cattle (302.86 per million), while testing schemes differed between 
MSs during this period of time. For example: Germany tested younger healthy stock than most MS. In 
the framework of BSE Passive Surveillance in EU17 during the period 2001 – 2011 a total 22 406 
bovine animals were tested and 2 407 were positive. 
Based on the available data, no BSE cases have been reported in EU17 in the framework of BSE 
Surveillance in 2011 in: Austria, Belgium, Cyprus, Denmark, Finland, Germany, Greece, Luxemburg, 
Netherlands, Slovenia and Sweden. Moreover, also in 2010 no cases have been reported in these same 
countries, except for Austria and Netherlands. Italy did not report any BSE case in 2010. 
With respect to the number of BSE cases detected through the BSE Active and Passive Surveillance 
and in the frame of eradication measures in EU17 from 2001 to 2011, the data per target group are 
reported in Table 3. 
 
                                                       
19    For further contract award details see http://ted.europa.eu/udl?uri=TED:NOTICE:393223-2011:TEXT:EN:HTML  Sample size healthy slaughter cattle BSE monitoring  
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Table 3:   Number of BSE cases detected through the BSE Active and Passive Surveillance and eradication measures in EU17 during the period 2001 – 
2011 per target group. 
Target Group 
No of detected BSE cases per testing year   
2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011  Total 
 Active Surveillance                         
  Healthy slaughtered  280  292  264  162  97  72  30  25  23  13  8  1 266 
  At risk animals                          
     Emergency slaughter  321  509  316  167  121  31  7  5  3  0  0  1 480 
     Fallen stock  400  610  406  308  212  161  92  75  31  28  19  2 342 
     Presenting Clinical signs at ante mortem inspection       35  24  31  11  16  9  4  2  0  0  0  132 
Total Active Surveillance  1 036  1 435  1 017  648  446  273  133  107  57  41  27  5 220 
Passive Surveillance                         
     Suspects subject to lab  1121  674  304  172  74  37  15  8  2  0  0  2 407 
Eradication Measures  9  10  3  5  13  1  1  3  0  0  0  45 
Total  2 166  2 119  1 324  825  533  311  149  118  59  41  27  7 672 
 
The trend observed in these data demonstrates that the control measures in place against BSE have been efficient because the  prevalence of the disease (i.e. 
number of positive cases out of the total number of tested animals in a given year) is declining exponentially in the EU17. This can also be seen in Figure 1 
below.  Sample size healthy slaughter cattle BSE monitoring  
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Figure 1:   Prevalence (log10 scale) of BSE in the EU17 found by Active and Passive surveillance 
from 2001 to 2011. In 2010 and 2011 no cases were reported in Passive surveillance. 
When modelling the log10 prevalence on the year, these declining trends on yearly prevalence in the 
EU17 are statistically significant for both the prevalence rates obtained within Active and Passive 
surveillance (beta values -0.16 and -0.27 for Active and Passive, respectively, with p<0.001 for both). 
The total number of BSE cases per birth cohort detected through BSE Surveillance (both Active and 
Passive) in EU17 during the period 2001 – 2003 and 2004 to 2011 are presented in Figure 2. In the 
EU17 there were two apparent consecutive waves of infection, the first in the mid 90‟s and a second 
one (lower number of cases involved) between 1998 and 2000. Sample size healthy slaughter cattle BSE monitoring  
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Figure 2:   Number of BSE cases per birth cohort detected through BSE surveillance (both Active 
and Passive) in EU17 during the periods 2001 to 2003 and 2004 to 2011. Y-axis scales from 0 to 1 500 
in the upper and form 0 to 300 cases in the lower figure.  
The trend of the average age of BSE cases per year of detection and incidence (i.e. number of positive 
cases out of the total adult cattle population older than 24 months of age in a given year) in the EU17, 
considering both BSE Active and Passive Surveillance are shown in Figure 3. Sample size healthy slaughter cattle BSE monitoring  
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Figure 3:   Incidence (log10 scale) of BSE in the EU17 per year of testing, considering both BSE 
Active and Passive Surveillance, and average age of those BSE cases for the given years.  
When fitting regression models using year of testing as independent variable, and the log10 incidence 
and the average age at year of testing as dependent variables respectively, both the declining trend in 
incidence and the increasing trend in average age are statistically significant in the EU17 (beta values -
-0.20 and +0.70 for incidence and average age, respectively, with p<0.001 for both). 
Concluding remarks on the trend of BSE in the EU 17 
  A constant decline in the total number of BSE cases per year (coming from both Active and 
Passive surveillance) has been recorded in EU 17: from 2 157 cases in 2001 to 27 cases in 
2011. 
  The  log10  transformed  annual  BSE  prevalence  and  incidence  within  EU17  (defined 
respectively as the number of positive BSE cases out of the tested population and out of the 
standing adult cattle population) shows a statistically significant decreasing trend. 
  Over the last 11 years, there has been a statistically significant increasing linear trend in the 
average age of the detected BSE cases in the EU17, which currently exceeds 11 years in each 
of these MSs (where reported in 2011).   
  When considering the birth cohort of the BSE cases in the EU17 there were two apparent 
consecutive waves of infections, the first in the mid 90‟s and a second one (lower number of 
cases involved) between 1998 and 2000. 
  Assuming that the age distribution of cattle tested for BSE within the EU17 MSs has not 
changed substantially over the considered period, the decreasing trend observed in the log10 
transformed annual BSE incidence and the increasing trend observed in the annual average 
age  of  the  cases  indicates  that  the  transmission  of  BSE  has  decreased  in  the  EU17  as  a 
consequence of the implementation of the control measures.  
  Data on BSE surveillance from 2001 to 2011 indicate that in the EU17 the BSE epidemic is 
fading out.  Sample size healthy slaughter cattle BSE monitoring  
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2.3.  Trend of BSE in the EU8 during the period 2004 to 2011 
Extensive epidemiological data on BSE has been collected in the framework of EU regulations via the 
BSE Active and Passive Surveillance over the last eight years in the EU8. Detailed tables on the 
epidemiological description of the trend of BSE are presented in Appendix A, while in this section 
summary tables and figures are presented. 
As addressed earlier on in this Report, it has to be noted that out of the eight MSs of interest, only 
three - referred to as EU3 - have reported positive BSE cases: Czech Republic, Poland and Slovakia. 
Thus, in five of the MSs of the EU8 group - referred to as EU5: Estonia, Hungary, Latvia, Lithuania 
and Malta - BSE cases have not been identified through the EU BSE monitoring regime. 
In the EU5 group, where BSE has not been identified, more than 1.9 million tests have been carried 
out in the framework of BSE Active surveillance between 2004 and 2011. Of these tests, about 1.68 
million were tests done in healthy slaughtered cattle, while approximately 240 000 at risk cattle were 
tested. 
In the EU 3 group, more than 6.2 million of tests have been carried out in the framework of BSE 
Active surveillance since 2004. Of these, 95 animals were positive. These included 63 out of 5425242 
healthy slaughtered cattle tested (11.61 per million healthy cattle tested), and 32 out of 862 751 at risk 
cattle tested (37.09 per million). In the framework of BSE Passive Surveillance in EU3 during the 
period from 2004  to 2011, a total of 169 bovine animals were tested and none was positive.  
In the framework of BSE Surveillance in 2011, only one BSE case has been reported in the EU3 (in 
Poland), whereas in 2010 three cases were reported, 2 in Poland and 1 in Slovakia, respectively. 
With respect to the number of BSE cases detected through the BSE Active and Passive Surveillance 
and in the frame of eradication measures in EU3 between 2004 and 2011, data per target group are 
presented in Table 4. 
 
 Sample size healthy slaughter cattle BSE monitoring  
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Table 4:   Number of BSE cases detected through the BSE Active and Passive Surveillance and from eradication measures in EU3 during the period 2004 – 
2011 per target group. 
Target Group 
No of detected BSE cases per testing year    
2004
1  2005  2006  2007  2008  2009  2010  2011  Total 
 Active Surveillance                   
  Healthy slaughtered  15  18  9  9  4  5  2  1  63 
  At risk animals 
                0 
     Emergency slaughter  5  2  0  1  2  0  0  0  10 
     Fallen stock  5  7  4  3  0  1  1  0  21 
     Presenting Clinical signs at ante mortem inspection       0  1  0  0  0  0  0  0  1 
Total Active Surveillance  25  28  13  13  6  6  3  1  95 
Passive Surveillance 
                0 
   Suspects subject to lab  0  0  0  0  0  0  0  0  0 
Eradication Measures  0  3  0  0  0  0  0  0  3 
Total  25  31  13  13  6  6  3  1  98 
1 In 2004, seven cases were diagnosed before 1 May. 
 
The trend observed in these data demonstrates that the control measures in place against BSE have been efficient because the prevalence of the disease is 
declining exponentially in the EU3. This can also be seen in Figure 4 below.  
 
 
 
 
 Sample size healthy slaughter cattle BSE monitoring  
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Figure 4:   Prevalence (log10 scale) of BSE in the EU8 found by Active surveillance from 2004 to 
2011. No cases were reported in EU8 by Passive surveillance. 
When comparing the prevalence in the EU8 for the period 2004 to 2009 with the prevalence in the 
EU17 for the period 2001 to 2006 (i.e. 6 first years of the total feed ban), it can be noticed that the 
yearly prevalence in the EU8 is in the range of 7 to 4 times lower than that of the EU17. 
As  for  the  EU17,  also  in  the  EU8,  when  modelling  the  log10  prevalence  on  the  year  there  is  a 
significant continuous declining trend on the yearly prevalence (beta -0.19, p<0.001). 
The total number of BSE cases per birth cohort detected through BSE Surveillance (both Active and 
Passive) in EU3 during the period 2004 to 2011 are presented in Figure 5. In the EU3 there were two 
apparent consecutive waves of infections, the first in the mid 90‟s and a second one (with larger 
number of cases involved) around the year 2000.  
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Figure 5:   Number of BSE cases per birth cohort detected through BSE Active surveillance in EU3 
during the period 2004 to 2011. 
The trend of the average age of BSE cases per year of detection and incidence in the EU8, considering 
both BSE Active and Passive Surveillance are shown in Figure 6. 
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Figure 6:   Incidence (log10 scale) of BSE in the EU8 per year of detection, considering both BSE 
Active and Passive Surveillance, and average age of those BSE cases for the given years. 
When fitting regression models using year of testing as independent variable, and the log10 incidence 
or the average age at testing as dependent variables, both the declining trend in incidence and the Sample size healthy slaughter cattle BSE monitoring  
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increasing trend in average age are statistically significant in the EU8 (beta values -0.18 and +0.95 for 
incidence and average age, respectively, with p<0.001 for both). 
Concluding remarks on the trend of BSE in the EU8 
  BSE has not been detected in five of the EU8 MSs (the EU5 group): Estonia, Hungary, Latvia, 
Lithuania and Malta. Three MSs (the EU3 group), these being Czech Republic, Poland and 
Slovakia, account for all the BSE cases detected in the EU8 group. 
  The number of BSE cases in the EU3 decreased from 28 in 2005 (peak) to one in 2011. 
  The log10 transformed annual BSE prevalence and incidence in the UE8 (defined respectively 
as the number of positive BSE cases out of the tested population and out of the standing adult 
cattle population) exhibits a statistically significant decreasing trend. 
  There has been a statistically significant increasing trend in the average age of the detected 
BSE cases in the EU8 per test year over the last eight years, which currently exceeds 11 years 
in each of these MSs (where reported in 2011).    
  When considering the birth cohort of the BSE cases in the EU3 there were two apparent 
consecutive  waves  of  infections,  the  first  in  the  mid  90‟s  and  a  second  one  (with  larger 
number of cases involved) around the year 2000.  
  Assuming  that  the  age  distribution  of  cattle  within  the  EU8  countries  did  not  change 
substantially  over  the  considered  period,  the  decreasing  trend  observed  in  the  log10 
transformed annual BSE incidence and the increasing trend observed in the annual average 
age  of  the  cases  indicates  that  the  transmission  of  BSE  has  decreased  in  the  EU8  as  a 
consequence of the implementation of the control measures. 
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3.  Atypical BSE in cattle 
Since its first report, Atypical BSE cases were described in a number of European and non-European 
countries. According to the data available in scientific literature or obtained through the EU active 
surveillance system, cases have been reported in several European countries (Jacobs et al., 2007; Stack 
et al., 2009), Japan (Masujin et al., 2008; Yamakawa et al., 2003), USA (Richt et al., 2007) and 
Canada (Dudas et al., 2010).  
Atypical BSE cases reported by the different EU MSs since 2001 are presented in Table 5. These data 
have to be interpreted with caution as in the EU there is no legal requirement for typing BSE positive 
cases  (i.e.  all  cases  traditionally  reported  as  BSE).  Thus,  the  data  presented  here  has  been  only 
reported in and ad hoc manner to the European Commission in the frame of the current and previously 
related  mandates.    Out  of  the  64  cases  reported  up  to  2011,  37  were  L-type  and  27  H-type, 
respectively. 
Table 5:   Atypical BSE cases reported in the EU MSs since 2001. Source: European Commission. 
Member State  Year of testing 
 
 
2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011  Total 
Austria 
            1      2    3 
Denmark 
      1                1 
France   1  3  4  1  1  2  2  5  4  3    26 
Germany 
  1    1                2 
Ireland 
  1                1  1  3 
Italy 
  1  1        1    1    1  5 
Netherlands  1  1  1              1    4 
Poland 
  1
1    2  2  2  2    1    1  11 
Spain 
                    1  1 
Sweden 
          1            1 
United Kingdom 
        1    2    1  1  2  7 
Total  2  8  6  5  4  5  8  5  7  8  6  64 
1Pre-May 2004 testing, before full implementation of EU regulations 
 
Reported Atypical BSE cases were detected almost exclusively in animals over 8 years of age (except 
for  one  case in a  6  year old  bovine reported in 2011).  All  these  cases  were  identified  by  active 
surveillance testing. However, there is currently no data available on the performance of the validated 
rapid assays used for cattle TSE testing, for detection of Atypical BSE cases, both in terms of their 
analytical sensitivity and of the efficacy of detection of infected asymptomatic animals.  
The number of Atypical BSE cases reported by EU MSs since 2001 by testing stream is included in 
table 6. 
Table 6:   Number of Atypical BSE cases reported by EU MSs since 2001 by testing stream. Source: 
European Commission. 
   Year of testing   
Target group   2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011  Total 
Fallen stock 
Healthy slaughtered animals 
1 
1 
3 
5 
4 
2 
2 
2 
2 
2 
2 
3 
7 
1 
4  4 
2 
6 
2 
4 
2 
39 
22 
Emergency slaughter        1        1  1       3 
Total  2  8  6  5  4  5  8  5  7  8  6  64 
 
Data presented in table 6 indicate that over the past decade  the majority of the reported Atypical BSE 
cases are in the fallen stock and healthy slaughter target groups (around 60% and 35% respectively), Sample size healthy slaughter cattle BSE monitoring  
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while only a few cases were detected in the emergency slaughter target group (around 5%). The 
number of Atypical BSE cases reported seems to be also rather stable throughout the years. In the 
EU17  group  of  MSs,  where  the  majority  of  the  BSE  cases  have  been  found,  most  of  the  cases 
identified over the past decade via active surveillance have been reported in the fallen stock target 
group. 
Figure 7 shows the average age of the Atypical L-BSE and H-BSE cases reported in the EU since 
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Figure 7:   Average age of the Atypical L-BSE and H-BSE cases reported in the EU since 2001 to 
2011. 
There is a significant increasing trend of the average age of the Atypical BSE cases of the two types 
combined (i.e. H-BSE and L-BSE), (beta +0.24, p= 0.02) in the EU25.The slope of this trend is less 
pronounced that it is in the case of the increasing trend of the average age of the  Classical BSE (C-
BSE) cases.  However, when assessing the trend individually for H-BSE and L-BSE, only a significant 
increasing trend in the yearly average age of the H-BSE cases is observed (beta +0.29, p=0.01), while 
for L-BSE the trend is not significant (beta=0.14, p=0.297).  
3.1.  Atypical BSE Type L (L-BSE) 
Atypical L-BSE has been reported to be transmissible to different animal models. In particular, intra-
cerebral (IC) inoculation of the L-BSE agent in cattle provokes a TSE which is both clinically and 
pathologically distinct from C-BSE (Lombardi et al., 2008). To date, there are no available results 
concerning the oral transmission of L-BSE in cattle.  
Bioassay in transgenic (Tg) mice over-expressing the bovine PrP
C seems to indicate that infectivity 
might disseminate in skeletal muscle tissues in animals IC challenged with L-BSE (Suardi et al., 
2012).  In contrast no infectivity was detected in the kidney, in the spleen and in lymph nodes from the 
same animal. Both abnormal PrP
Sc deposits and infectivity (detected by bioassay in tg-Bov mice) was 
also observed in a naturally infected but asymptomatic BSE L case (Polak and Zmudzinski, 2012; 
Suardi et al., 2012). 
In  Classical BSE cases, pathogenesis studies have established that abnormal PrP deposition in the 
brainstem first occurs at the obex level, where substantial amount of this disease specific protein 
accumulates during the late incubation phase (Arnold et al., 2007; Simmons et al., 2010; Wells et al., Sample size healthy slaughter cattle BSE monitoring  
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2007). As a consequence, targeting obex for C-BSE rapid testing is considered as the most sensitive 
approach for detecting cases within the framework of the active surveillance system. 
In Atypical BSE (both L and H type), the dynamics of the abnormal PrP deposition in the different 
brain areas is poorly documented, and the suitability of the obex as the target tissue for testing that 
would allow an early and sensitive detection of these conditions remain largely unknown. On one 
hand,  all  the  Atypical  BSE  cases  detected  so  far  were  identified  through  the  active  surveillance 
system, indicating that obex testing with currently validated tests allows the detection of at least a part 
of the Atypical cases. However, on other hand the distribution of abnormal PrP in L-BSE, as observed 
from a very limited number of samples, clearly indicates that brainstem deposition of abnormal PrP in 
the context of L-BSE is poor by comparison to other areas (Casalone et al., 2004; Konold et al.; Polak 
and  Zmudzinski,  2012).  This  last  finding  strongly  support  the  contention  that  active  surveillance 
system as currently applied could have a more limited sensitivity to detect Atypical BSE cases than C-
BSE cases in field cattle population. 
Proof of principle of the L-BSE ability to propagate in sheep was brought by the IC propagation of a 
L-BSE isolate into ARQ/ARQ and in Tg mice expressing the ovine PrP
C variants. The propagation of 
L-BSE in sheep seemed to result in a TSE with a different profile to that of C-BSE (Nonno et al., 
2008). Unexpectedly, L-BSE isolates transmitted to either Tg mice expressing ovine PrP
C (Beringue et 
al., 2007) or inbred wild-type mouse lines (Capobianco et al., 2007) resulted in a disease with similar 
phenotypic features to those of the C-BSE agent. However, the inoculation of tissues collected in mice 
over-expressing  ovine  PrP
C  inoculated  with  C-BSE  and  L-BSE  in  bovine  PrP
C  transgenic  mice, 
resulted into two different phenotypes specific of each agent indicating that the tg338 passaged agents, 
although producing a similar signature in the brain, were actually different (Beringue et al., 2010). 
Results from several studies that focus on the potential human risk from Atypical L-BSE are available. 
Kong and colleagues (2008) investigated the infectivity and phenotype of L-BSE by IC inoculating Tg 
mice expressing the human PrP
C (M129M) with brain homogenates from two L-BSE affected cattle. 
Sixty percent of the inoculated Tg mice became infected after 20-22 months incubation, a transmission 
rate higher than those reported for C-BSE. A quarter of L-BSE infected Tg mice, but none of the Tg 
mice infected with sporadic CJD (sCJD), showed presence of PrP
res in the spleen, indicating that the 
L-BSE  agent  may  be  lymphotropic.  The  pathological  prion  protein  isoforms  in  L-BSE  infected 
humanized Tg mouse brains were different from those of the original cattle L-BSE or sCJD. Minimal 
brain spongiosis and long incubation time were observed in the L-BSE infected Tg mice. A similar 
study was performed in another Tg mice expressing the human PrP
C (M129M- Tg650) (Beringue et 
al., 2008). In contrast with C-BSE prions, L-BSE prions appeared to propagate in these mice with no 
obvious transmission barrier. Another study evaluated the transmission of L-BSE to a non-human 
primate  (Comoy  et  al.,  2008).  Brain  homogenates  from  cattle  with  C-BSE  and  L-BSE  were  IC 
inoculated into cynomolgus monkeys (Macacca fascicularis). The single monkey infected with L-BSE 
had a shorter survival, and a different clinical evolution, histopathology, and prion protein (PrP
res) 
pattern than what was observed for either C-BSE or vCJD-inoculated animals. These results were 
interpreted to suggest a possibly higher degree of pathogenicity of L-BSE than C-BSE in primates. 
Taken  together,  these  experimental  studies  may  demonstrate  that  L-BSE  or  BASE  is  easily 
transmissible to both humanised mice and primates, and may be more virulent to humans than C-BSE.  
More recently transmission of L-BSE into bank voles resulted in a TSE which phenotype (incubation 
period, PrP
Sc biochemical properties and vacuolar lesion profiles) were identical to the one observed 
after transmission of a VV2 s-CJD case in this rodent model (Nonno et al., 2009). 
Finally, it has to be mentioned that there is no data available about the impact of the TSE inactivation 
process currently applied to processed animal proteins (133°C, 2 Bar pressure, 20 minutes) on the 
infectivity of the L-BSE agent. Sample size healthy slaughter cattle BSE monitoring  
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3.2.  Atypical BSE Type H (H-BSE) 
There is currently no data available on the pathogenesis and the tissue infectivity distribution of H-
BSE in ruminants.  
H-BSE has been transmitted into a number of laboratory animal models. In most of the reported cases 
the transmission features obtained were distinct from those observed after inoculation with C-BSE 
(Beringue et al., 2006). However,  a recently published work  described the transmission of four 
French and one Polish H-BSE isolates into transgenic mice expressing bovine PrP
C (Tg110 mice) by 
IC challenge (Torres et al., 2011). Following these transmissions, two H-BSE isolates resulted in the 
propagation in some mice (respectively 3 and 2 out of 12) of a TSE displaying a C-BSE phenotype. 
Second passage of prions into TgBov mice confirmed that the TSE agent was C-BSE. 
These results imply that C-BSE might emerge spontaneously from an H-BSE type isolate (in the 
absence of any interspecies passage), which could indicate that H-BSE might be a source of the C-
BSE agent. This hypothesis is also consistent with the observed trend in the average age of cases. 
Finally and equally to L-BSE, there is no data about the impact of the TSE inactivation process 
currently applied to processed animal proteins on the infectivity of the H-BSE Agent. 
3.3.  Concluding remarks on Atypical BSE 
The following can be concluded regarding Atypical BSE: 
  The origin and pathogenesis of Atypical forms of BSE in its natural host are unknown.  
  Epidemiological data reported by the EU MSs indicate that over the last years the number of 
detected  Atypical  BSE  cases  did  not  show  any  trend  and  that  these  cases  were  mainly 
identified in the fallen stock and healthy slaughtered animals older than 8 years of age.  
  The  performance  of  the  current  TSE  monitoring  system,  both  in  terms  of  its  analytical 
sensitivity and earliness of the detection of animals infected with Atypical BSE is unknown.  
4.  A brief overview of existing BSE surveillance and risk models 
Modelling  has  been  applied  quite  intensively  on  BSE,  with  different  aims  and  using  different 
approaches to adapt to available data.  
Existing BSE surveillance and risk models can be separated in two main categories: Models for data-
rich  situations  and  models  for  data-sparse  situations.  Data-sparse  models  are  quite  rare,  and  are 
generally risk models, that look at the risk of introduction or of transmission of BSE considering 
available  test  samples  results.  The  data-rich  models  again  separate into two  categories:  statistical 
models and predictive models, where the predictive models are generally an extension of a statistical 
data analysis model.  
4.1.  Data-sparse models 
Data-sparse models (i.e. sparse case data) are rare. The EFSA Geographical BSE Risk Assessment is a 
good  example  of  a  reasonably  good  assessment  of future  risk  was  made  based  on  rather  limited 
information, (EFSA, 2007). 
For parameter-sparse models, the OIE point system
20 for evaluation of surveillance is also available. 
This is not a model in the  classical sense but to be considered as a criterion, which was based on 
evaluation of EU case data from the early active surveillance period,  based on the  BSurvE model 
(Prattley et al., 2007). Various risk categories were determined with relative risk, leading to the points 
                                                       
20 For further details see: http://www.oie.int/fileadmin/Home/eng/Health_standards/tahc/2010/en_chapitre_1.11.5.htm  Sample size healthy slaughter cattle BSE monitoring  
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accredited to these categories. Although extrapolation of these risk estimates to other situations and 
non-randomized surveillance data is not scientifically sound, it surely offers a very simple evaluation 
method.  
4.2.  Statistical models 
The statistical models analyse existing BSE case data and negative test data, aiming to provide 1.) a 
prediction of the prevalence in the selected population, 2.) to analyse the BSE trend in time, or 3.) to 
increase the sensitivity of the surveillance system. Most of these models include the age structure and 
an age-dependent case-risk functions.  
Examples of these models are the BSurvE model (Prattley et al., 2007), models considered in former 
EFSA Opinions (EFSA, 2008a, 2009, 2010; Prattley et al., 2007) and that published in 2008 by de 
Koeijer (de Koeijer, 2008). A similar approach of analysing the trend of BSE has been the application 
of  Age-Period-Cohort  (APC)  regression  models  (Ducrot  et  al.,  2010;  Sala  and  Ru,  2009).  APC 
modelling, commonly used in the assessment of cancer trends, is based on the analysis of tested 
animals (in term of age at testing, date of testing  i.e. period, and birth cohort): it may provide a 
calculation of the evolution of BSE risk over successive birth cohorts allowing the comparison of 
trends by country and the identification of difference in the probability of infection of subsequent 
cohorts. 
Back calculation models are very detailed models offering more precision than more simple models. 
These  models  derive  several  transmission  relations,  like  the  age  dependent  susceptibility,  age 
dependent mortality etc. simultaneously from the data, while also analysing (historical) prevalences.  
4.3.  Predictive models 
Predictive extensions to the statistical models are made based either on linear extrapolation or on 
mechanistic analysis. Although back-calculation models are in theory less suitable for extrapolation, 
this can be solved as easily as with the less detailed categorizing models. However, the precision 
gained in the model will get lost with the extrapolation, while such a model remains more “black-
box”- like, in the sense that all the computations performed within the modelling process are not easily 
evident. Sample size healthy slaughter cattle BSE monitoring  
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5.  Estimating  sample  sizes  of  healthy  slaughtered  cattle  over  72  months  of  age  for  the 
monitoring and surveillance of TSEs 
Following an EFSA open call for tender (CT/EFSA/BIOHAZ/2002), a model to estimate sample sizes 
of healthy slaughtered cattle to be tested in order to meet a given design prevalence has been provided 
by a contractor (Animal Health and Veterinary Laboratories Agency (AHVLA), UK). This model was 
called the Cattle-TSE Monitoring Model, to be referred to as C-TSEMM from now onwards.  
The full report submitted to EFSA by the contractor should be read as part of this EFSA Scientific 
Report (Adkin et al., 2012). 
5.1.  Methodology, limitations and assumptions  
The probabilistic statistical C-TSEMM model employs a framework developed in R software
21 with a 
Visual Basic
22 software interface. The detailed description of the structure of the model can be found 
in the contractor‟s Report (Adkin et al., 2012).  
The model uses EU data on prevalence of infection by birth-cohort and demographic information, 
which is employed  to  estimate  the  design  prevalence  and the  sensitivity  of  a  monitoring  system. 
European Commission and EU member states provided the relevant data. It has to be noticed that the 
models estimates presented in this report are based on the 2011 demographics of the adult cattle 
population and on the number of adult cattle removed from the population via the different streams 
(i.e.  healthy  slaughter,  animals  showing  clinical  signs  of  disease  during  ante  mortem  inspection, 
emergency slaughtered animals and fallen stock). Therefore, future fluctuations in those numbers at 
EU level and in each MSs will impact the validity of current estimates. Thus, should the C-TSEMM 
model be employed in future years for the review of the BSE monitoring regime in the EU, updated 
yearly data including BSE testing data have to be considered as these drive the results estimated by the 
model. 
Based on the model approach, the number of animals of the healthy slaughter exit stream that need to 
be tested, in order that  at least one animal is detected with a probability of  τ, is given by using 
binomial formulae. This is an approximation to the hypergeometric distribution, which would be the 
correct distribution for a sampling scheme without replacement.  
Testing for BSE is a testing procedure without replacement, but the approximation by the binomial 
distribution is acceptable is n < 0,1N. If we compare the means and the standard deviations of the 
binomial and the hypergeometric distributions we immediately see that the means are identical but the 
standard deviations differ by the factor sqrt((N-n)/(n-1)). This factor is called the finite populations 
factor and is always less or equal to one. If n<0,1N, the corresponding binomial and hypergeometric 
probabilities  correspond  close  enough  (see  C-TSEMM  sensitivity  analysis,  section  5.4.  of  the 
contractor‟s Report, (Adkin et al., 2012)). In the simulation model the hypergeometric distribution is 
replaced by the binomial distribution because the model becomes computationally more tractable.  
When  dealing  with  the  relationship  between  sample  size  and  design  prevalence  in  this  report, 
calculations are presented taking into account both the standing adult cattle population and the tested 
adult cattle population, both of them older than 24 months of age. Thus, the definitions of prevalence 
in the contractor‟s Report (Adkin et al., 2012) and as presented in this section of the EFSA Report here 
are as follows: 
  Detectable prevalence in test population: Period prevalence in a given year of detectable 
infected animals in the test population. Calculated by the model‟s predicted number of adult 
animals  (>24  months),  in  the  population  of  animals  tested,  that  would  test  positive  by  a 
diagnostic test, divided by the total number of animals tested in one year. 
                                                       
21    www.cran.r-project.org 
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  Infection  prevalence  in  test  population:  Period  prevalence  in  a  given  year  of  infected 
animals in the test population. Calculated by the model‟s predicted number of adult animals 
(>24 months), in the population of animals tested, that are actually infected (i.e. animals that 
may or may not test positive or be showing clinical symptoms) divided by the total number of 
animals tested in year. 
  Detectable  prevalence  in  standing  population:  Period  prevalence  in  a  given  year  of 
detectable infected animals in the standing population. Calculated by the model‟s predicted 
number of adult animals (>24 months), in the standing population, that would test positive by 
a diagnostic test, divided by the total number of adult animals in the standing population. 
In the context of BSE monitoring, addressing prevalence in the tested cattle population is usually 
considered  of  greater  epidemiological  value  than  addressing  prevalence  in  the  standing  cattle 
population. This is because the population of study of BSE is the tested population, which is not a 
random representation of the standing population but part of the population that is slaughtered (or 
dead).  Furthermore  the  predicted  detectable  prevalence  in  the  standing  population  can  never  be 
validated. Nevertheless, results are presented considering also the standing population as this forms 
part of the technical request made by the Commission. 
A series of assumptions are made in the C-TSEMM, which need to be considered when evaluating the 
outputs from the model (Adkin et al., 2012). These assumptions can be categorised in two groups: 
a.  Assumptions made when transforming input data. These include: 
  For MSs with no, or few, BSE cases post-2001 (i.e. Austria, Cyprus, Estonia, Finland, 
Greece,  Hungary,  Latvia,  Lithuania,  Luxembourg,  Malta  and  Sweden)  an  alternative 
estimate of cohort-based prevalence is required. This has been estimated for those MSs 
based on the average prevalence of the group of MSs with BSE cases under which they 
were placed in previous related EFSA Opinions  (EFSA, 2009, 2010), theEU17 or the 
EU8 group
23. This results in an overestimate of prevalence for countries with no recorded 
cases as they are assumed to be a merged epidemiological unit with countries where cases 
are observed (see Appendix C of the contractor‟s report (Adkin et al., 2012) for further 
details).  
  Whilst the healthy slaughter, emergency slaughter, fallen stock and clinical suspects of 
BSE seem to be populated to a similar degree within European countries, clinical signs at 
ante mortem does not seem to be uniformly applied. When considering the definition of 
the emergency slaughter category there appears little to distinguish between the categories 
and therefore it has been agreed that the clinical signs at AM stream can be merged into 
the emergency slaughtered stream. 
  Animals  culled  under  the eradication  measures are  traditionally  difficult  to  include  in 
modelling work as for most countries there are insufficient test positive data to estimate 
prevalence on a cohort basis. These were incorporated into the fallen stock category with 
the impact of this assumption investigated in section 5.1 of the contractor‟s Report (Adkin 
et al., 2012). 
  The proportion of animals > 155 months in the (i) slaughtered/dead, and (ii) standing 
population, by 12 month intervals to 204 months (17 years) is not known for most MSs. 
Therefore, the assumption was made that the proportions by 12 monthly intervals could be 
approximated by that recorded in (i) the UK slaughtered/dead population between 2008 
                                                       
23   EU17: Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, 
Portugal, Slovenia, Spain, Sweden and United Kingdom. EU8: Czech Republic, Estonia, Hungary, Latvia, Lithuania, 
Malta, Poland and Slovakia. Sample size healthy slaughter cattle BSE monitoring  
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and 2010, and (ii) an average of that recorded in Austria and the UK standing population 
in 2010. Assumption (i) has been tested in the sensitivity analysis and could be replaced 
by assuming equal proportions by 12 monthly intervals without impacting results (refer to 
section 5.2 of the contractor‟s Report (Adkin et al., 2012)).  
  Data are absent for the standing population for most MSs in 2011. It is assumed that the 
data for 2010 can be used as a proxy.  
  Age data are transformed into cohort based testing data assuming an equal probability per 
month of birth and death. 
  There are little experimental data to assess the sensitivity of the BSE test in cattle. It is 
assumed that we can use data based on 1g experimentally dosed cattle as detailed in 
Arnold et al. (2007) to approximate the sensitivity of the test for field cases. 
b.  Model assumptions. These include: 
  Underpinning the estimate of true prevalence it is assumed that the use of an exponential 
distribution to model the true prevalence is appropriate. While other distributions could be 
fitted,  analysis  of  alternative  distributions  has  indicated  that  an  exponential  decay  of 
prevalence over time is appropriate for the majority of European data (section 5.3 of the 
contractor‟s Report (Adkin et al., 2012)).  
  Cases from the clinical suspect (CS) stream and fallen stock (FS) stream are assumed to 
be identified at the end of the incubation period, that is, death is as a result of the disease. 
Whereas healthy slaughter (HS) and emergency slaughter (ES) animals may be within a 
period of time before clinical onset depending on the distribution of the age at onset and 
test  sensitivity.  This  assumption  impacts  the  number  of  infected  animals  within  these 
streams.  
  Prevalence estimated for the combined streams (i.e. clinical suspects and fallen stock, 
healthy slaughter and emergency slaughter) can be divided into the individual exit streams 
according to the proportion of test positive animals observed in those streams. Where 
there are no test positives, it is assumed that the number of animals tested by birth cohort 
and testing year is an appropriate proxy. 
  It is assumed that all cases of BSE are typed by strain such that the number tested for  
Classical and unknown strains is the same number as that tested for Atypical H and L 
type. This is not the case for all MSs and therefore only simulations from MSs where 
strain differentiation is routinely conducted will be valid.  
  The  design  prevalence  calculation  is  based  on  an  infinite  population  (sampling  with 
replacement) which is based on the binomial distribution. This method is straightforward 
to  implement,  however,  for  MSs  with  small  slaughter  populations,  the  use  of  the 
hypergeometric distribution produces lower estimates for the number to test to achieve a 
desired design prevalence. This has been investigated in the sensitivity analysis (section 
5.4  of  the  contractor‟s  Report  (Adkin  et  al.,  2012)).  The  conclusion  is  that  for  those 
countries with a small slaughter population, the number of animals needed to be tested is 
still greater than the number that are actually tested with the exception of Finland which 
has a marginal reduction in the number to test using the hypergeometric equation. For all 
other MSs that are not achieving a sufficient design prevalence to reduce current levels of 
testing,  conclusions  are  not  affected  whether  the  hypergeometric  or  binomial  based 
sample  size  formula  is  used. The impact  of  the  use  of  the  binomial  could  be  further 
explored with the application in the field of a “sampling with replacement” strategy in 
BSE monitoring. However, that is not currently feasible under the current BSE testing Sample size healthy slaughter cattle BSE monitoring  
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practices (i.e. post mortem testing) and may proof challenging even with a theoretical live 
animal testing BSE monitoring regime. 
  In estimating either the re-emergence of an existing TSE, or emergence of a new TSE 
disease in cattle, it is assumed that the disease can be detected by current testing assays.   
  For simulating the EU25 as a whole, it is assumed that it can be merged as an unique 
epidemiological unit or territory. 
 Sample size healthy slaughter cattle BSE monitoring  
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5.2.  Results  
5.2.1.  Estimated design prevalence of the current BSE monitoring system 
Table 7 shows the results for different design prevalence calculations that would be detected by the baseline monitoring regime in place in the EU25 as a 
whole and by the MSs individually with τ% confidence. Results are provided based on the detectable prevalence (prevalence of cases) for the adult standing 
population and adult tested population, together with results based on the infection prevalence (prevalence of infected animals) for the adult tested population. 
This considers all cases recorded in the Commission BSE database including the “unknown” strains.  
The baseline monitoring regime is the testing of healthy slaughter animals > 72 months, emergency slaughter and fallen stock > 48 months and the testing of 
all clinical suspect animals. Results are expressed as 1 in X, so a result of 100 000 indicates that we would expect the current system to detect a prevalence in 
adult cattle >24 months of 1 in 100 000. For the main results τ=95%, to show the uncertainty surrounding these estimates we also present results for τ=92.5% 
and τ=97.5%.  Design prevalence results are shaded where the estimated prevalence detected is greater than the threshold of 100 000. As  the level of 
confidence is increased from τ=92.5% to τ=97.5%, it can be seen from the table that the estimated design prevalence reduces in sensitivity. N/A in Table 7 
indicates that model has failed to converge, and thus not being able to provide estimates based on the country-specific data characteristics of those MSs 
 
Table 7:   Estimated design prevalence of baseline monitoring system for all strains, using detectable prevalence in the tested population and standing 
population, and infection prevalence in the tested population to a confidence (τ) of 95% (lower 92.5% and upper 97.5% confidence). Shaded results show that 
the estimated prevalence detected is greater than the threshold of 100 000. 
MS 
Estimated „design prevalence‟ of baseline monitoring system considering all strains and unknown 
Detectable prevalence in standing population (1 in X)  Detectable prevalence in tested population (1 in X)  Infection prevalence in tested population (1 in X)   
τ=0.925  τ=0.95  τ=0.975  τ=0.925  τ=0.95  τ=0.975  τ=0.925  τ=0.95  τ=0.975   
EU25    7 349 693    6 354 930  5 160 828   2 304 889     1 992 928  1 618 454    706 953   611 268   496 410 
AT  142 490    123 205  100 056   55 885    48 321  39 242  14 318    12 380  10 054  
BE  323 067  279 342  226 854  74 519  64 433  52 326  20 168  17 438  14 162 
CY   6 136  5 306  4 310   N/A   N/A   N/A  461  N/A  N/A 
CZ  60 099  51 965  42 201  31 586  27 311  22 181  5 766  4 985  4 049 
DE  899 533  777 784  631 638  323 633  279 831  227 250  81 585  70 542  57 287 
DK  N/A  N/A  N/A  44 659  N/A  31 359  15 408  13 323  10 819 Sample size healthy slaughter cattle BSE monitoring  
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MS 
Estimated „design prevalence‟ of baseline monitoring system considering all strains and unknown 
Detectable prevalence in standing population (1 in X)  Detectable prevalence in tested population (1 in X)  Infection prevalence in tested population (1 in X)   
τ=0.925  τ=0.95  τ=0.975  τ=0.925  τ=0.95  τ=0.975  τ=0.925  τ=0.95  τ=0.975   
DK*  274 347  237 147  192 626  44 662  38 612  31 357  15 414  13 333  10 825 
EE  16 443   14 220  11 548  6 239  5 395  4 381  1 319  1 140  N/A 
EL  N/A  N/A  N/A  8 076   6 983  5 672   2 668   2 307   N/A 
ES  294 174  254 359  206 565  141 902  122 696  99 624  43 943  37 995  30 856 
FI   108 035   90 365  74 692  N/A   17 661  14 343   6 219   5 378   4 367 
FR  2 005 412  1 733 985  1 408 168  603 303  521 647  423 629  236 882  204 821  166 335 
HU  37 393  32 332  26 257  19 805  17 124  13 907  3 800  3 286  2 669 
IE  527 100  455 760  370 123  127 587  110 318  89 590  56 919  49 215  39 968 
IT  319 226  276 020  224 155  139 500  120 619  97 937  24 298  21 010  17 062 
LT  28 060  N/A  19 703  21 459  18 555  15 069  3 301  N/A  2 318 
LU  1 4 896   12 881  10 461   2 926   2 530  2 055  1 273   1 101   894 
LV  18 833  16 284  13 224  11 155  9 646  7 833  1 689  1 460  1 186 
MT  N/A  N/A  545  N/A  N/A  N/A  115  100  N/A 
NL   336 577   290 828  236 340   110 685    94 162  77 722    29 881   25 836   N/A 
PL  210 665  182 152  147 926  166 199  143 704  116 702  28 646  24 769  20 115 
PT  73 615  63 652  51 692  N/A  N/A  N/A  9 720  8 405  6 825 
SE   116 259   101 010  81 484   29 845   25 805  20 957    7 675   6 636   5 389 
SI  17 683  15 290  12 417  8 115  7 017  5 699  2 355  2 036  1 654 
SK  16 423  14 200  11 532  8 884  7 682  6 239  1 842  1 592  1 293 
UK   785 476   679 164  551 548   246 037  212 736  172 763  62 482  54 025  43 874 
N/A=the model has failed to find a viable value. 
*Values for Denmark using alternative solver routine 
 Sample size healthy slaughter cattle BSE monitoring  
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From Table 7 it can be seen that the calculation using the detectable prevalence in the standing population produces the highest estimates for the design 
prevalence  the  baseline  monitoring  system  is  able  to  detect.  Twelve  MSs  (i.e.  Austria,  Belgium,  Denmark,  Germany,  Spain,  France,  Ireland,  Italy, 
Netherlands, Poland, Sweden and the UK) have a design prevalence of at least 1 in 100 000 using the estimated detectable prevalence to a confidence level of 
95%. The EU25 „design prevalence‟ is higher than for individual MSs as far more animals are tested, with an estimated design prevalence of 1 in 6 354 930 .  
N/A in Table 7 indicates that model has failed to converge. This is due to the use of a solver to calculate the estimated „design prevalence‟ a monitoring 
system is able to detect by the rearrangement of the design prevalence equation (see Equation 2 in Appendix B, contractor‟s Report (Adkin et al., 2012)), 
where the „design prevalence‟ value is solved for a specified number of animals tested. The generic solver routine has been optimised to produce results for 
the majority of MSs. When considering the detectable prevalence in the standing population, a viable value has not been found at the 95
th confidence value for 
Greece, Lithuania, and Malta.  Based on other confidence values and the estimated number to test values provided in Table 8 below, the design prevalence of 
these countries is not meeting the 1 in 100 000 threshold. However, for Denmark it is likely that at the 95
th confidence value, the monitoring system is 
detecting greater than 1 in 100 000. To investigate that value for Denmark, the generic solver routine was adapted specifically for Denmark. Results using the 
specific solver routine for Denmark are denoted in the table with an asterisk. 
For the remaining MSs in Table 7 (i.e. Czech Republic, Cyprus, Estonia, Finland, Hungary, Luxembourg, Latvia, Portugal, Slovenia and Slovakia) the design 
prevalence the baseline monitoring system is able to detect ranges between 1 in 5 306 and 1 in 90 365 with a confidence level of 95%. 
Using the estimated detectable prevalence in the tested population  to a confidence level of 95%, the baseline monitoring regimes in seven MSs (Germany, 
Spain, France, Ireland, Italy, Poland and UK) have a design prevalence of at least 1 in 100 000. Additionally, France has a design prevalence greater than 1 in 
100 000 estimated using the prevalence of infection in the tested population.  The EU25 „design prevalence‟ is higher than for individual MSs as far more 
animals are tested, with an estimated design prevalence of 1 in 1 992 928 using the detectable prevalence in the tested population and 1 in 611 268 using the 
prevalence of infection in the tested population. The assumption is made that the EU25 can be estimated as a merged epidemiological unit or territory.  
 Sample size healthy slaughter cattle BSE monitoring  
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5.2.2.  Estimated number to test in healthy slaughter stream to achieve a design prevalence of 1 in 100 000 
Table 8 shows the number of healthy slaughter animals that would need to be tested, given the number of animals currently being tested in the other exit 
streams remains the number tested in those streams in 2011, in order to be τ(%) confident of detecting a positive animal if the overall prevalence in animals 
>24 months is 1 in 100 000. As in table 7, results are provided based on the detectable prevalence (prevalence of cases) for the adult standing population and 
adult tested population, together with results based on the infection prevalence (prevalence of infected animals) for the adult tested population. For the main 
results τ=95%, to show the uncertainty surrounding these estimates we also present results for τ=92.5% and τ=97.5%.  Results for the number of healthy 
slaughter animals to be tested are shaded where the estimated number is less than current testing in this exit stream. This considers all cases recorded in the 
Commission BSE database including the “unknown” strains. 
 
Table 8:   Estimated number of health slaughtered animals required to be tested for all strains, given testing of emergency slaughter, fallen stock and clinical 
suspect animals, to achieve a design prevalence of 1 in 100 000 using detectable prevalence in the tested population and standing population, and infection 
prevalence in the tested population to a confidence (τ) of 95% (lower 92.5% and upper 97.5% confidence). Shaded results show that the estimated prevalence 
detected is greater than the threshold of 100 000.   
MS
1 
    Number to test in healthy slaughter to detect prevalence of 1 in 100 000 considering all strains and “unknown” 
  Detectable prevalence in standing population  Detectable prevalence in tested population  Infection prevalence in tested population 
Actual number tested  
in HS >72 m (2011)  τ=0.925  τ=0.95  τ=0.975  τ=0.925  τ=0.95  τ=0.975  τ=0.925  τ=0.95  τ=0.975 
EU25  3 730 778  0  0  0  0  0  0  0  0  0 
AT  104 147   40 014   63 640   104 029   273 920   334 160   437 140  1  391 111  1  626 229  2  028 165 
BE  112 059  0  0  0  206 255  264 120  363 041  1 202 488  1 416 297  1 781 805 
CY  2 140   86 023   100 011   123 925   317 062  367 215    452 954  1  187 398  1  373 789  1  692 427 
CZ  42 984  89 981  108 418   139 936  196 307  231 387  291 358  1 199 928  1 392 110  1 720 646 
DE  513 746  0  0  0  0  0  0  786 379  1 018 122  1 414 290 
DK  55 260  0  0  0  304 008  374 366  494 643  1 157 284  1 361 209  1 709 820 
EE  7 739  80 328   93 927  117 189  222 438  258 282  319 557  1 076 700  1 246 265  1 536 138 
EL  12 428  175 599    207 618   262 356   483 513  563 732     700 865  1  522 610    1 765 482  2  180 675 
ES  255 669  0  0  0  13 615  104 038  258 615  1 301 366  1 593 365  2 092 539 
FI  27 041   22 168   34 146
2   54 623   344 146  406 524    513 161  1  254 421  1  459 289    1 809 512 
FR  1 013 355  0  0  0  0  0  0  0  0  0 
HU  24 700  94 256  111 647  141 376  192 920  225 755  281 887  1 076 287  1 247 399  1 539 917 
IE  241 637  0  0  0  0  132 508  377 213  1 124 731  1 445 597  1 994 120 Sample size healthy slaughter cattle BSE monitoring  
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MS
1 
    Number to test in healthy slaughter to detect prevalence of 1 in 100 000 considering all strains and “unknown” 
  Detectable prevalence in standing population  Detectable prevalence in tested population  Infection prevalence in tested population 
Actual number tested  
in HS >72 m (2011)  τ=0.925  τ=0.95  τ=0.975  τ=0.925  τ=0.95  τ=0.975  τ=0.925  τ=0.95  τ=0.975 
IT  255 135  28 898  45 052  72 667  161 855  198 821  262 014  1 281 486  1 493 712  1 856 516 
LT  41 066  159 684  185 494  229 616  210 401  244 149  301 843  1 396 379  1 615 774  1 990 832 
LU  3 738   107 523   126 612  159 243    606 397    703 576    869 704  1  412 466    1 635 822  2 017 652  
LV  21 766  125 166  145 106  179 195  212 838  246 502  304 051  1 418 127  1 640 460  2 020 541 
MT  416  95 368  110 347  135 954  115 067  133 130  164 008  647 505  748 912  922 270 
NL  165 855  0  0  0  125 683   184 533   285 137  1  142 364  1  360 358    1 733 022 
PL  310 559  103 168  132 503  182 651  153 308  190 491  254 057  1 293 962  1 509 697  1 878 497 
PT  43 450  96 547  128 047  181 897  384 982  461 632  592 667  1 419 381  1 657 950  2 065 786 
SE  45 963   31 314   45 417  69 525    292 182   347 119   441 035  1  305 964  1  519 593    1 884 793 
SI  10 595  159 945  188 345  236 895  373 843  435 725  541 514  1 340 888  1 554 145  1 918 712 
SK  9 721  114 198  133 766  167 217  220 263  256 433  318 266  1 103 870  1 278 355  1 576 639 
UK  409 609  0  0  0  0  0  82 639  875 767  1 070 258  1 402 744 
1 See Appendix B for MS acronyms 
2 In the case of Finland the number of healthy slaughter cattle to test using the hypergeometric equation is estimated to be 16 2333, less than the number tested in 2011  
 
Considering the estimated detectable prevalence in the standing population, in Table 8 we can see that when the EU25 is merged into one epidemiological 
unit, the area already tests sufficient animals in the ES, FS and CS streams such that they do not need to test any healthy slaughter animals (represented in the 
table by a value of 0). Thus, the C-TSEMM model estimates that, with the current BSE monitoring regime but excluding the testing of healthy slaughter cattle, 
the system is able to detect in the standing population one BSE case in 4 021 940 adult cattle with a confidence level of 95%. 
Also considering the estimated detectable prevalence in the standing population, at a confidence level of 95%, eight MSs (i.e. Belgium, Germany, Denmark, 
Spain, France, Ireland, Netherlands, and the UK) do not require the testing of any healthy slaughter animals to meet a 1 in 100 000 design prevalence.  
Also based on detectable prevalence in the standing population, four MSs (i.e. Austria,  Italy, Poland and Sweden) do require testing less healthy slaughtered 
animals older than 72 months of age than the total number tested in those MSs in 2011 in order to meet a 1 in 100 000 design prevalence. In the remaining 
thirteen MSs (i.e. Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, Latvia, Lithuania, Luxembourg, Malta, Portugal, Slovenia and Slovakia) the 
number of healthy slaughtered animals older than 72 months of age that would need to be tested in order to meet a 1 in 100 000 design prevalence is higher 
than the actual number tested in 2011. In the case of Finland, the number of healthy slaughter cattle to test if the hypergeometric equation would be used 
instead of the binomial one is estimated to be less than the number tested in 2011. Sample size healthy slaughter cattle BSE monitoring  
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However, it has to be noted that in the context of the current BSE monitoring system (i.e. post mortem test carried out in slaughtered cattle or dead cattle of 
certain age categories), fitting a sample size larger than the actually slaughtered cattle population is neither feasible nor realistic. Thus, the current testing of all 
animals of certain age categories that are slaughtered or dead, may provide the most sensitive BSE monitoring system possible (i.e. that employs post mortem 
tests) under the current epidemiological scenario with the potential limitation on the impact of the age at testing as evaluated in former EFSA Opinions 
(EFSA, 2008a, 2008b, 2009, 2010). 
One potential consideration could be given to those MSs where the sample size is larger than the actual cattle population size. In that case, an alternative could 
be to consider extending (e.g. from one to more years) the time frame given to meet the design prevalence.  However, this would not be in line with the 
technical aspects of the terms of reference (i.e. yearly design prevalence). 
The calculations using the standing population prevalence show the lowest number of animals that need to be tested when compared to results using the 
detectable prevalence in the test population. The estimate of the numbers of animals needing to be sampled in order to detect a prevalence of 1 in 100 000 is 
lower (and thus the power of the surveillance in Table 8 is higher) when considering the standing population than when considering the test population. This is 
because the prevalence of BSE in the standing population is lower than the prevalence in the test population. As such, assuming a design prevalence of 1 in 
100 000 in the standing population, as opposed to in the test population, will lead to higher stream prevalences in the test population after the appropriate 
scaling. In other words, a design prevalence of 1 in 100 000 in the standing population will lead to a greater than 1 in 100 000 prevalence in the test population 
(the design prevalence used when considering the test population). Therefore, the standing population prevalence calculations are effectively performed at a 
higher overall BSE prevalence than the test population calculations, leading to smaller sample sizes.  
Using the estimated detectable prevalence in the tested population, we can see that when the EU25 is merged into one epidemiological unit, the area 
already tests sufficient animals in the ES, FS and CS streams such that they do not need to test any healthy slaughter animals (represented in the table by a 
value of 0).  At a confidence level of 95%, three MSs (i.e. Germany, France, and the UK) do not require to test any healthy slaughter animals to meet 1 in 
100000 design prevalence given the other exit streams are tested. Italy (IT), for example, with a confidence level of 95%, is required to test 198 821 HS 
animals. As Italy (IT) currently tests 255 135 there is a reduction in the animals required to be tested to achieve the desired design prevalence.  Luxembourg 
(LU) is required to test 703 576 HS animals, but only test 3 738 so that MS will not achieve the design prevalence.   
When using the estimated infection prevalence in the tested population only France and the EU25 as a whole achieve the required confidence with no 
testing of healthy slaughter animals required. The differences in the results between MSs are based on the estimated ratio of the prevalence in each of the four 
testing streams and how many animals are tested per year in those streams.  France, for example, has a relatively high prevalence in FS and CS testing streams 
and tests a large number of animals within these streams. Therefore, for France the design prevalence is met without the requirement for testing in the healthy 
slaughter stream.   
 Sample size healthy slaughter cattle BSE monitoring  
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5.2.3.  Estimated number of BSE cases missed should healthy slaughtered cattle testing stop 
Table 9 displays, based on simulations done by the model, the predicted number of BSE cases (i.e. this considers all cases recorded in the Commission BSE 
database including the “unknown” strains) detected by the monitoring baseline and scenario and the total number of infected animals slaughtered/dead over 
one year. The baseline monitoring regime involves the testing of healthy slaughter animals > 72 months, emergency slaughter and fallen stock > 48 months 
and the testing of all clinical suspect animals. The scenario regime only affects the healthy slaughter stream in that no healthy slaughtered animals are tested. 
The mean values are presented, together with the 95% confidence intervals in brackets. For comparison purposes, the actual number of test positives for 2011 
are shown in the second column by exit stream. The final column on the right hand side displays the total number of infected animals slaughtered/dead (for all 
four streams including all age groups) irrespective the testing scheme applied. 
Table 9:   Estimated mean number of cases missed and infected animals missed of all strains given a change in the monitoring regime from the baseline to a 
scenario where no healthy slaughter animals are tested with 95% confidence intervals (CI*). 
MS
1 
  Number of animals missed between monitoring baseline and scenario in one year considering all strains and “unknown” 
Actual cases in 2011 
{HS,ES,FS,CS}  Baseline detected [CI
*]  Scenario detected[CI
*] 
Number detected missed [CI
*] 
 (baseline - scenario) 
Number infected animals dead [CI
*] 
(all streams, all age groups)      
EU25  28 { 9, 0, 19, 0 }  28 [  11 , 148 ]  18 [  5.6 , 132 ]  10 [ 5.2 , 16 ]  100 [  59 , 247 ]     
AT  0  0.53 [ 0.74 , 101 ]  0.27 [ 0.71 , 100 ]  0.25 [ 0.03 , 0.52 ]  2.4 [ 1.1 , 104 ]     
BE  0  0.22 [ 0.71 , 100 ]  0.13 [ 0.7 , 100 ]  0.09 [ 0.01 , 0.19 ]  0.99 [ 0.81 , 102 ]     
CY  0  0.03 [ 0.66 , 96 ]  0.02 [ 0.66 , 96 ]  0.01 [ 0.001 , 0.02 ]  0.12 [ 0.67 , 96 ]     
CZ  0  0.86 [ 0.77 , 98 ]  0.34 [ 0.7 , 97 ]  0.52 [ 0.07 , 1.05 ]  7.5 [ 2.6 , 110 ]     
DE  0  3.6 [ 1.3 , 107 ]  2 [ 0.98 , 104 ]  1.5 [ 0.36 , 2.79 ]  20 [ 7.9 , 132 ]     
DK  0  0.01 [ 0.69 , 100 ]  0.01 [ 0.68 , 100 ]  0.004 [ 0.0004 , 0.01 ]  0.05 [ 0.69 , 100 ]     
EE  0  0.07 [ 0.67 , 96 ]  0.03 [ 0.66 , 96 ]  0.04 [ 0.004 , 0.08 ]  0.52 [ 0.72 , 97 ]     
EL  0  0.09 [ 0.69 , 100 ]  0.06 [ 0.69 , 100 ]  0.03 [ 0.003 , 0.06 ]  0.30 [ 0.72 , 100 ]     
ES  7 { 4, 0, 3, 0 }  16 [ 5.7 , 128 ]  11 [ 3.4 , 120 ]  5 [ 2.3 , 7.92 ]  60 [  32 , 190 ]     
FI  0  0.23 [ 0.71 , 100 ]  0.16 [ 0.7 , 100 ]  0.08 [ 0.009 , 0.16 ]  0.98 [ 0.81 , 102 ]     
FR  3 { 0, 0, 3, 0 }  2.9 [ 1.1 , 105 ]  2.2 [ 0.98 , 104 ]  0.69 [ 0.14 , 1.32 ]  8.2 [ 2.6 , 115 ]     
HU  0  0.26 [ 0.66 , 93 ]  0.11 [ 0.64 , 92 ]  0.15 [ 0.018 , 0.32 ]  2 [ 0.94 , 96 ]     
IE  3 { 0, 0, 3, 0 }  3.9 [ 1.3 , 107 ]  3.1 [ 1.1 , 106 ]  0.81 [ 0.18 , 1.51 ]  9.5 [   3 , 117 ]     
IT  1 { 1, 0, 0, 0 }  0.31 [ 0.72 , 100 ]  0.07 [ 0.69 , 100 ]  0.24 [ 0.027 , 0.50 ]  2.2 [   1 , 104 ]     
LT  0  0.2 [ 0.68 , 96 ]  0.02 [ 0.66 , 96 ]  0.17 [ 0.019 , 0.36 ]  1.7 [ 0.89 , 99 ]     
LU  0  0.04 [ 0.69 , 100 ]  0.03 [ 0.69 , 100 ]  0.009 [ 0.001 , 0.02 ]  0.11 [ 0.7 , 100 ]     
LV  0  0.11 [ 0.67 , 96 ]  0.01 [ 0.66 , 96 ]  0.098 [ 0.011 , 0.21 ]  0.95 [ 0.78 , 98 ]     
MT  0  0.004 [ 0.66 , 96 ]  0.002 [ 0.66 , 96 ]  0.0025 [ 0.00026 , 0.01 ]  0.043 [ 0.66 , 96 ]     
NL  0  0.4 [ 0.73 , 100 ]  0.24 [ 0.71 , 100 ]  0.16 [ 0.019 , 0.33 ]  1.8 [   0.95 , 103 ]     Sample size healthy slaughter cattle BSE monitoring  
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MS
1 
  Number of animals missed between monitoring baseline and scenario in one year considering all strains and “unknown” 
Actual cases in 2011 
{HS,ES,FS,CS}  Baseline detected [CI
*]  Scenario detected[CI
*] 
Number detected missed [CI
*] 
 (baseline - scenario) 
Number infected animals dead [CI
*] 
(all streams, all age groups)      
PL  1 { 1, 0, 0, 0 }  1.2 [ 0.82 , 98 ]  0.26 [ 0.69 , 96 ]  0.96 [ 0.14 , 1.93 ]  8.9 [   3 , 112 ]     
PT  5 { 3 0 2 0 }  3.1 [ 1.1 , 106 ]  2.2 [ 0.97 , 104 ]  0.91 [ 0.17 , 1.74 ]  11 [ 3.5 , 119 ]     
SE  0  0.31 [ 0.72 , 100 ]  0.18 [ 0.7 , 100 ]  0.13 [ 0.02 , 0.26 ]  1.5 [ 0.89 , 103 ]     
SI  0  0.39 [ 0.7 , 97 ]  0.26 [ 0.69 , 96 ]  0.13 [ 0.016 , 0.27 ]  1.9 [ 0.94 , 100 ]     
SK  0  0.56 [ 0.73 , 97 ]  0.3 [ 0.69 , 97 ]  0.27 [ 0.034 , 0.54 ]  4.6 [ 1.6 , 105 ]     
UK  8 { 0, 0, 8, 0 }  11 [ 3.2 , 120 ]  5.2 [ 1.5 , 110 ]  5.8 [ 1.7 , 10.29 ]  44 [  20 , 171 ]     
1 See Appendix B for MS acronyms 
*Confidence intervals are results from using upper and lower 95% Poisson confidence interval values about the model predictions 
 
If testing in the healthy slaughter stream were to cease, an estimated mean 10 cases (95% CI: 5.2, 16) across the EU25 (when the EU25 is merged into one 
epidemiological unit) would have been missed in 2011. The estimated number missed can be compared against the background estimated number of 100 
infected animals slaughtered/dead which includes those animals which, if tested, would test negative. 
The number of missed cases estimated by the C-TSEMM model based on detectable cases can be compared with those estimated by the model employed in 
the EFSA Scientific Opinion of 2010 on a second update of the risk to human and animal health on the review of the BSE monitoring regime in some MSs 
(EFSA, 2010). That Scientific Opinion estimated that should testing of healthy slaughtered cattle be completely stopped but maintaining testing of the at risk 
animal group in animals older than 48 months of age, less than three Classical BSE cases would have been missed in the EU17 in 2011 under a “more 
realistic”
24 scenario. When comparing these results, the following has to be noted: 
  The C-TSEMM model employs new BSE data collected in 2011; 
  The C-TSEMM model considers the EU25 MSs, while the former EFSA model considers the MSs in the EU17 group; 
  The lower limit of the CI of the C-TSEMM model result is 5.2;  
  The C-TSEMM model considers all cattle BSE strains (i.e. including Atypical BSE) while the former EFSA model considers only Classical BSE. 
Considering Atypical BSE would fit better under the “worst case” scenario of the former EFSA model, which may be consistent with a constant trend 
of BSE. The result based on the “worst case” scenario of the former EFSA model was that less than seven cases would be missed. 
Comparison between these two models should be made with caution due to the differences in their methodology and in the scope of their use. Still, the 
estimates of the C-TSEMM model regarding number of detectable cases missed if testing of healthy slaughtered cattle were to be stopped in 2011 are in line 
with the estimates presented in the EFSA Opinion from 2010, taking account of the different scenario‟s and datasets used.  
  
                                                       
24 The “more realistic” scenario of the model in the EFSA 2010 Opinion considers a declining  Classical BSE trend based on the historical BSE data available at the time, while a “worst case 
scenario” was also presented based on a constant prevalence of  Classical BSE in birth cohorts since 2004.  Sample size healthy slaughter cattle BSE monitoring  
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5.2.4.  Estimated number of years to detect an hypothetical increase in the prevalence of  Classical BSE 
Table 10 displays the model predictions of the estimated number of years taken to detect a hypothetical annual 10% increase in  Classical BSE cases (i.e. 
consider cases recorded as “ Classical” and “unknown” strains in the Commission BSE database) given an emergence initiated in 2011. The assumption is 
made that detection will occur when the number of model predicted cases exceeds the upper confidence interval prediction of number of cases for 2011 (upper 
confidence interval prediction is calculated in the baseline model using the upper 95% Poisson confidence interval values for the input test positive data).  
Results for the number of cases (detectable) and the number of infected animals between 2011 and the year of detection are provided, based on an annual 10% 
increase in the number of test positive animals. 
Table 10:   Estimated number of years to detect a hypothetical increase in prevalence of 10% per year with “Classical” and “unknown” strains starting in 
2011, together with estimates of the number of detectable cases and infected animals missed during that time interval between the scenario and baseline 
model. 
MS
1 
Number of years to detect an hypothetical annual 10% increase in prevalence of  Classical and “unknown” strains and estimated number of positive cases missed  
Current number 
test positives 
(baseline, 
scenario) 
Upper CI 
limit
+ 
( 0.975) 
Years to detection (i.e. 
cross upper CI limit) 
(baseline , scenario) 
Total test positives 
at detection 
(baseline, scenario) 
Number of extra 
cases under scenario 
before detection 
(scenario-baseline) 
Total infected 
animals at 
detection 
 (baseline, 
scenario) 
Number of extra infected animals dead 
under scenario before detection 
(scenario-baseline) 
EU25  26.85 , 16.98  40.34  6 , 11  207.14 , 314.70  107.56  694.87 , 1,668.93  974.06 
AT
*  0.49 , 0.25  0.73  6 , 13  3.79 , 6.21  2.41  15.47 , 49.15  33.69 
BE  0.20 , 0.12  0.62  13 , 19  5.03 , 6.22  1.2  19.85 , 41.41  21.56 
CY
*  0.03 , 0.02  0.04  6 , 11  0.19 , 0.28  0.09  0.79 , 1.90  1.11 
CZ  0.85 , 0.33  4.07  18 , 28  38.81 , 44.84  6.04  254.63 , 749.45  494.82 
DE  3.64 , 2.11  10.9  13 , 19  89.31 , 108.02  18.72  385.01 , 803.20  418.19 
DK  0.03 , 0.02  0.24  25 , 29  2.68 , 2.76  0.07  9.57 , 14.47  4.89 
EE
**  0.09 , 0.04  0.46  19 , 27  4.55 , 5.07  0.52  24.32 , 57.57  33.25 
EL
*  0.08 , 0.06  0.12  5 , 9  0.51 , 0.79  0.28  1.67 , 3.70  2.04 
ES  15.37 , 10.57  27.2  7 , 11  145.77 , 195.88  50.11  510.50 , 997.16  486.66 
FI
*  0.22 , 0.15  0.33  6 , 10  1.71 , 2.36  0.65  5.97 , 12.33  6.36 
FR  2.64 , 1.99  6.65  11 , 14  48.87 , 55.71  6.84  129.50 , 195.49  65.99 
HU
**  0.29 , 0.12  1.5  19 , 28  14.94 , 16.16  1.22  93.81 , 246.11  152.29 
IE  3.54 , 2.81  6.7  8 , 11  40.50 , 52.05  11.55  92.02 , 149.12  57.09 
IT  0.32 , 0.07  1.26  16 , 32  11.41 , 13.56  2.15  73.05 , 408.69  335.64 
LT
**  0.22 , 0.02  1.07  18 , 41  10.12 , 11.97  1.85  78.38 , 838.52  760.14 Sample size healthy slaughter cattle BSE monitoring  
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MS
1 
Number of years to detect an hypothetical annual 10% increase in prevalence of  Classical and “unknown” strains and estimated number of positive cases missed  
Current number 
test positives 
(baseline, 
scenario) 
Upper CI 
limit
+ 
( 0.975) 
Years to detection (i.e. 
cross upper CI limit) 
(baseline , scenario) 
Total test positives 
at detection 
(baseline, scenario) 
Number of extra 
cases under scenario 
before detection 
(scenario-baseline) 
Total infected 
animals at 
detection 
 (baseline, 
scenario) 
Number of extra infected animals dead 
under scenario before detection 
(scenario-baseline) 
LU
*  0.04 , 0.03  0.06  5 , 8  0.25 , 0.37  0.12  0.59 , 1.10  0.51 
LV
**  0.12 , 0.01  0.6  18 , 43  5.70 , 7.12  1.43  43.75 , 568.36  524.62 
MT
**  0.01 , 0.00  0.03  19 , 27  0.27 , 0.29  0.02  1.94 , 4.58  2.65 
NL  0.46 , 0.28  2.76  20 , 26  26.31 , 30.18  3.87  106.48 , 202.98  96.5 
PL  1.51 , 0.31  10.33  22 , 38  107.91 , 112.65  4.74  727.28 , 3,707.99  2,980.72 
PT  2.82 , 2.00  6.38  10 , 14  44.90 , 55.87  10.98  143.20 , 251.36  108.16 
SE
*  0.27 , 0.15  0.4  6 , 12  2.10 , 3.26  1.16  8.80 , 24.38  15.58 
SI  0.39 , 0.26  3.59  25 , 29  38.38 , 38.88  0.5  144.29 , 218.06  73.77 
SK  0.56 , 0.29  3.82  22 , 28  39.78 , 39.38  -0.4  227.80 , 428.17  200.38 
UK  10.61 , 5.00  21.13  9 , 17  144.05 , 202.55  58.5  571.95 , 1,707.70  1,135.75 
1 See Appendix B for MS acronyms 
*Uses EU17 test positive data.
  **Uses EU8 test positive data, 
+Using model fit on 95
th Poisson CI input values 
 
From Table 10 it can be seen that across the EU25 (when the EU25 is merged into one epidemiological unit) detection of the emergence would take an 
estimated 6 years for the baseline monitoring system and 11 years for the scenario monitoring regime. In this intervening five years an additional estimated 
108 test positives would be required for the number of cases to be greater than the threshold, and an estimated extra  974 infected animals would be 
slaughtered/die.  
It has been noted that the countries that use the EU17 test positive data, as a proxy, in the absence of cases between 2002-2011, have a fairly short time to 
detection (i.e. until the model predicted number of cases is greater than the upper threshold value). This early detection is based on the relatively low level of 
uncertainty associated with the EU17 data and thus the upper CI limit is relatively close to the current number tested. The real level of uncertainty in the 
individual MSs is higher, due to a smaller sample size. Therefore the model underestimates the time to detection for these countries.  A similar scenario exists 
for the countries using the EU8 test positive data, but to a lesser degree as it is a smaller sample size than the EU17. Therefore, the results for countries 
denoted with asterisk(s) in Table 10 could be considered to represent the combined MSs of the EU8 and EU17 rather than individual country time to detection.  
For the remaining MSs, it can be seen that Spain has the shortest estimated time to detection of 7 years under the baseline monitoring regime, while both Spain 
and Ireland have the joint shortest estimated time to detection of 11 years under the scenario monitoring regime. The monitoring system of France and Ireland Sample size healthy slaughter cattle BSE monitoring  
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are estimated to be least affected by the lifting of testing from healthy slaughtered animals, with only three additional years to detect the significant increase. 
Italy and Poland‟s monitoring regimes are estimated to be the most affected, with a difference of 16 years between the baseline and monitoring regimes.  
The Upper CI limit for the current testing year (2011) in each MS was selected as a means to determine when a MS will „detect‟ that there has been a 
significant increase in the annual number of cases.  This approach may not be a realistic method that would be implemented to detect an emergence within the 
EU25, however, it provides a simple, comparative measure that can be generically applied across all MSs, strains and monitoring regimes without additional 
assumptions. The upper CI limit for the Slovakia (SK) in 2011 was 3.82, indicating that a significant increase in the number of cases would be detected when 
a year with greater than 3.82 cases occurs. For SK, the estimated number of cases, when considering a 10% from the current testing year, was greater than 
3.79 at 22 years for the baseline regime, and 28 years after under the scenario regime.  Over these time periods (22 and 28 years) the model estimates a total of 
approximately 39.78 observed cases under the baseline regime and 39.38 cases under the scenario regime. The negative results for SK for the number of 
additional cases are not intuitive, in that there is an estimated additional six years for detection for the scenario regime but this accounts for less cases in total.    
This is due to the lack of testing of HS animals in the scenario regime, for most other MS‟s estimates the scenario regime takes sufficiently longer to detect the 
increase that more cases are detected overall.  It is useful to compare the difference in the number of cases with the difference in the number of infected 
animals dead/slaughtered between monitoring regimes. For SK it can be seen from the table that although the scenario regime detects the theoretical increase 
with less observed cases, due to the additional year of testing required, an additional 200 infected animals would be slaughtered/die when comparing the 
regimes. 
Whilst Table 10 provides the time to detection for the baseline monitoring system and the scenario of no testing of healthy slaughtered animals, Table 11 
below provides the results for the scenario where testing could be reduced by certain MSs to achieve a 1 in 100 000 design prevalence. For those countries 
shaded in Table 8, the testing of healthy slaughtered animals could be reduced to achieve a design prevalence of 1 in 100 000 at the 95% confidence value, 
using the detectable prevalence in the standing population. Given the estimated number of healthy slaughter animals to test, Table 11 shows the results for the 
number of years to detect for those countries with reduced testing. The first column on the left hand side of Table 8 refers to the percentage reduction 
calculated from the number to test for that MS divided by the total number of healthy slaughter animals tested. For example, the results from Table 8 suggest 
that Austria is required to test 63 640 HS animals to achieve a design prevalence of 1 in 100 000.  Austria currently tests 104 147 HS animals, which suggests 
that they only need test 61% of their HS animals (63 640/104 147*100).  Sample size healthy slaughter cattle BSE monitoring  
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Table 11:   Estimated number of years to detect a hypothetical increase in prevalence of 10% per year with “Classical” and “unknown” strains starting in 
2011, together with estimates of the number of detectable cases and infected animals missed during that time interval between the scenario and baseline 
model, where the scenario is testing the proportion of HS slaughter suggested by the results in Table 8 for the standing population with τ=0.95. 
MS
1 
  Number of years to detect an annual 10% increase in prevalence of Classical and “unknown” strains and estimated number of 
positives missed 
Proportion HS 
>72 months 
tested 
Current number 
test positives 
(baseline, 
scenario) 
Upper CI 
limit
+ 
( 0.975) 
Years to detection 
(i.e. cross upper CI 
limit) (baseline , 
scenario) 
Total test 
positives at 
detection 
(baseline, 
scenario) 
Number of extra 
cases under 
scenario before 
detection 
(scenario-
baseline) 
Total infected 
animals at detection 
 (baseline, scenario) 
Number of extra 
infected animals 
dead under scenario 
before detection 
(scenario-baseline) 
EU25  0  26.85 , 16.98  40.34  6 , 11  207.14 , 314.70  107.56  694.87 , 1,668.93  974.06 
AT
*  0.61  0.49 , 0.40  0.73  6 , 8  3.79 , 4.56  0.76  15.47 , 22.92  7.46 
BE  0  0.20 , 0.12  0.62  13 , 19  5.03 , 6.22  1.2  19.85 , 41.41  21.56 
DE  0  3.64 , 2.11  10.9  13 , 19  89.31 , 108.02  18.72  385.01 , 803.20  418.19 
DK  0  0.03 , 0.02  0.24  25 , 29  2.68 , 2.76  0.07  9.57 , 14.47  4.89 
ES  0  15.37 , 10.57  27.2  7 , 11  145.77 , 195.88  50.11  510.50 , 997.16  486.66 
FR  0  2.64 , 1.99  6.65  11 , 14  48.87 , 55.71  6.84  129.50 , 195.49  65.99 
IE  0  3.54 , 2.81  6.7  8 , 11  40.50 , 52.05  11.55  92.02 , 149.12  57.09 
IT  0.18  0.32 , 0.11  1.26  16 , 27  11.41 , 13.51  2.1  73.05 , 246.06  173.01 
NL  0  0.46 , 0.28  2.76  20 , 26  26.31 , 30.18  3.87  106.48 , 202.98  96.5 
PL  0.43  1.51 , 0.82  10.33  22 , 28  107.91 , 110.35  2.44  727.28 , 1,367.01  639.73 
SE
*  0.99  0.27 , 0.27  0.4  6 , 6  2.10 , 2.09  -0.01  8.80 , 8.80  0 
UK  0  10.61 , 5.00  21.13  9 , 17  144.05 , 202.55  58.5  571.95 , 1,707.70  1,135.75 
1 See Appendix B for MS acronyms 
*Uses EU17 test positive data.
   
+Using model fit on 95
th Poisson CI input values 
 
From Table 11 it can be seen that for those MS where no healthy slaughter animals are required to be tested to achieve a 1 in 100 000 design prevalence in the 
standing population (i.e. those MSs with a 0 in the first column: EU25, BE, DE, DK, ES, FR, IE, NL and UK) the number of years to detect an increase in 
prevalence is the same between Table 10 and Table 11 where the scenario is no healthy slaughter testing. For those MSs where partial testing achieves the 
level of confidence required, results are between the baseline (100% testing of healthy slaughter > 72 months) and the scenario of no healthy slaughter testing 
results given in Table 10. For example, for Austria, under the scenario of no healthy slaughter testing, the number of years to cross the upper confidence 
interval is achieved at 13 years (Table 10), whereas with the random sampling of 61% of healthy slaughtered animals > 72 months, thus achieving an 
estimated 1 in 100 000 design prevalence, detection is achieved at 8 years (Table 11).  Sample size healthy slaughter cattle BSE monitoring  
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5.2.5.  Estimated number of Atypical BSE cases missed should healthy slaughtered cattle testing stop 
France was selected as an individual MS case study as the country has the highest number of L and H type strain typed within EU25 MS datasets.   
Table 12 displays the comparison of the estimated number of Atypical cases detected by the baseline and scenario regimes and, as a comparison, the estimated 
number of infected animals slaughtered/dead for the case study France. The baseline monitoring regime is the testing of healthy slaughter animals > 72 
months, emergency slaughter and fallen stock > 48 months and the testing of all clinical suspect animals. The scenario regime only affects the healthy 
slaughter stream in that no healthy slaughtered animals are tested. The mean values are presented, together with the 95% confidence intervals in brackets 
Table 12:   Estimated mean number of cases missed and infected animals missed comparing separate calculation of Atypical L and H type with all strains 
given a change in the monitoring regime from the baseline to a scenario where no healthy slaughter animals are tested with 95% confidence intervals (CI*). 
MS 
  Number of Atypical BSE cases missed between monitoring baseline and scenario 
Actual cases 
2011  
{HS,ES,FS,CS}  Baseline detected [CI
*]  Scenario detected[CI
*] 
Number detected missed 
 (baseline - scenario) 
Number infected animals dead [CI
*] 
(all streams, all age groups)  
FR*-L&H strains  0  1.3 [ 0.84 , 102.20 ]  0.94 [ 0.8 , 101.55 ]  0.32 [ 0.045 , 0.64 ]  3.4 [ 1.2 , 106.44 ] 
FR-All strains and “unknown”  3 { 0, 0, 3, 0 }  2.9 [ 1.1 , 105.30 ]  2.2 [ 0.98 , 103.98 ]  0.69 [ 0.14 , 1.32 ]  8.2 [ 2.6 , 114.81 ] 
*FR=France 
 
From Table 12 it can be seen that, for France, the estimated number of cases missed between the baseline and scenario monitoring regimes is approximately 
the same for both strain combinations, that is approximately 24%-25% of the cases currently detected would not be detected under a regime of no healthy 
slaughter testing.  
When analysing results using only the Atypical data, it is assumed that all cases of BSE are typed by strain such that the number tested for  Classical and 
unknown strains is the same number as that tested for Atypical H and L type. This is not the case for all MSs, and therefore only simulations from MSs where 
strain differentiation is routinely conducted will be valid.  
 
 Sample size healthy slaughter cattle BSE monitoring  
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5.2.6.  Estimated number of years to detect an hypothetical increase in the prevalence of Atypical BSE 
As per results presented in section 5.2.5, France was selected as an individual MS case study as the country has the highest number of L and H type strain 
typed within EU25 MS datasets.   
Table 13 displays a comparison between the estimated number of years taken to detect a hypothetical 10% increase in French cases between  Classical and 
unknown data and Atypical L and H type strain types. France was selected as the case study as the country has the highest number of L and H type strain 
typed within EU25 MS datasets. Results for the number of cases (detectable) and the number of infected animals between 2011 and the year of detection are 
provided, based on an annual 10% increase in the number of test positive animals. Note, when analysing results using only the Atypical data only simulations 
from MSs where strain differentiation is routinely conducted will be valid.  
Table 13:   Estimated number of years to detect a hypothetical increase in prevalence of 10% per year in France for different strains starting in 2011, together 
with estimates of the number of detectable cases and infected animals missed during that time interval for the baseline model 
MS 
Number of years to detect an hypothetical annual 10% increase in prevalence of Atypical BSE and estimated number of positive cases missed  
Current number 
test positives 
(baseline, 
scenario) 
Upper CI 
limit 
( 0.975) 
Years to detection (i.e. 
cross upper CI limit) 
(baseline , scenario) 
Total test positives 
at detection 
(baseline, scenario) 
Number of extra 
cases under scenario 
before detection 
(scenario-baseline) 
Total infected 
animals at detection 
 (baseline, scenario) 
Number of extra 
infected animals dead 
under scenario before 
detection  
(scenario – baseline) 
FR*-L&H 
strains  1.26 , 0.94  10.95  24 , 27  111.70 , 114.20  2.49  304.88 , 417.20  112.32 
FR-Classical 
and “unknown”  2.64 , 1.99  6.65  11 , 14  48.87 , 55.71  6.84  129.50 , 195.49  65.99 
*FR=France 
From Table 13 it can be seen that, for France (FR), the upper CI limit in 2011 was an estimated 11 for Atypical strains and 6.7 for  Classical and unknown 
strains, indicating that a significant increase in the number of cases would be detected when a year with greater than 11 or 6.7 cases occurs. For FR, the 
estimated number of Atypical cases was greater than 11 after 24 years for the baseline regime, and 27 years under the scenario regime. Over these time periods 
(24 and 27 years) the model estimates a total of approximately 112 observed cases under the baseline regime and 114 cases under the scenario regime. For  
Classical and unknown strains the results are similar, with the estimated number of cases greater that the upper threshold at 11 years for the baseline and 14 
years for the scenario monitoring regime. Between these years an estimated 49 cases and 56 cases were observed. The results for France can be compared to 
those provided in Table 6 for all strains, where the estimated years to cross the upper CI limit were 11 and 14 years for the baseline 
 
 
 Sample size healthy slaughter cattle BSE monitoring  
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5.2.7.  Concluding Remarks 
The cattle TSE Monitoring Model (C-TSEMM) has a series of assumptions that have to be considered 
when interpreting the estimates provided by this. Among those assumptions, a key one is that for MSs 
with no, or few, BSE cases post-2001 an alternative estimate of cohort-based prevalence is required. 
This has been estimated for those MSs based on the average prevalence of the group of MSs with BSE 
cases under which they were placed in previous EFSA Opinions (EU17 or theEU8 group)
25. This 
results in an overestimate of prevalence for countries with no recorded cases as they are assumed to be 
a merged epidemiological unit with countries where cases are observed. 
Based on the estimates provided by the C-TSEMM model that considered prevalence in the standing 
adult cattle population (i.e. Period prevalence in a given year of detectable infected animals in 
the  standing  population)  and  the  available  historical  EU  wide  data  on  BSE  monitoring,  the 
following provides support to the reply of the quantitative aspects of the request received from the 
European Commission: 
  In the EU25 as a whole: 
o  The current BSE monitoring regime enables the detection of one BSE case in  6 354 
930 adult cattle (i.e. older than 24 months of age) with a confidence level of 95%.  
o  If  the  current  BSE  monitoring  regime  would  exclude  testing  of  healthy  slaughter 
cattle, it would be able to detect in the standing population one BSE case in 4 021 940 
adult cattle with a confidence level of 95%. Therefore, no healthy slaughter animals 
need to be tested in order to meet a design prevalence of one detectable case in 100 
000 adult cattle, since testing of at risk animals (i.e. animals showing clinical signs 
during ante mortem inspection, emergency slaughter animals and fallen stock over 48 
months  of  age,  and  clinical  suspects)  is  sufficient  to  meet  the  proposed  design 
prevalence.  
  At individual MS level: 
o  In eight MSs (Belgium, Germany, Denmark, Spain, France, Ireland, Netherlands, and 
the UK) the testing of any healthy slaughter animals is not needed in order to meet a 1 
in 100 000 design prevalence with a confidence level of 95%, since testing of at risk 
animals is sufficient to meet the proposed design prevalence.    
o  In four MSs (Austria, Italy, Poland and Sweden) the testing of a fraction of healthy 
slaughtered animals older than 72 months of age (i.e. on the basis of the number tested 
in  2011)  would  be  sufficient  to  meet  a  1  in  100  000  design  prevalence  with  a 
confidence level of 95%. 
o  In thirteen MSs (Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, Latvia, 
Lithuania, Luxembourg, Malta, Portugal, Slovenia and Slovakia) the number of tested 
animals  in  2011  (i.e.  including  all  the  healthy  slaughtered  animals  older  than  72 
months of age) did not allow to meet a 1 in 100 000 design prevalence with 95% 
confidence. However, fitting a sample size larger than the actually slaughtered cattle 
population of a MS is neither feasible nor realistic. Thus, the current testing of all 
animals of certain age categories that are slaughtered or dead may provide the most 
sensitive BSE monitoring system possible (i.e. that employs post mortem tests) under 
the current epidemiological scenario with the potential limitation on the impact of the 
                                                       
25   EU17: Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, 
Portugal, Slovenia, Spain, Sweden and United Kingdom;  
       EU8: Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland and Slovakia Sample size healthy slaughter cattle BSE monitoring  
 
EFSA Journal 2012;10(10):2913  46 
age at testing as evaluated in former related EFSA Opinions
26.  
o  Regarding  Classical BSE: 
  Based on a theoretical scenario of an annual 10% increase in detectable cases 
in the tested population (prevalence), the C-TSEMM model estimates that: 
  In  the  EU25  as  a  whole,  where  testing  healthy  slaughtered  cattle 
above  and  age  of  72  months  is  not  needed  in  order  to  meet  the 
proposed design prevalence, the time to detection of the supposed 
10% yearly increase in detectable cases would increase from six to 11 
years ( i.e. five extra years to detect the supposed 10% yearly increase 
in  prevalence  of  detectable  cases)  should  testing  of  healthy 
slaughtered cattle be stopped compared to the current testing regime.  
  In those MSs where testing healthy slaughtered cattle above the age 
of  72  months  is  not  needed  in  order to  meet the proposed  design 
prevalence  (Belgium,  Denmark,  France,  Germany,  Ireland, 
Netherlands,  Spain and  the  UK), it  would take  between  three and 
eight extra years (depending on the MS) to detect that yearly increase 
in prevalence should testing of healthy slaughtered cattle be stopped 
compared to the current testing regime. 
  In  those  MSs  where  testing  healthy  slaughtered  cattle  could  be 
reduced in order to meet the proposed design prevalence (Austria, 
Italy, Poland and Sweden), it would take between six and 16 extra 
years  (depending  on  the  MS)  to  detect  that  yearly  increase  in 
prevalence should testing of healthy slaughtered cattle older than 72 
months of age be reduced to the number needed to meet the proposed 
design prevalence compared to the current testing regime. 
  In those MSs where testing healthy slaughtered cattle older than 72 
months  of  age  as  per  the  current  BSE  monitoring  regime  is  not 
sufficient  to  meet  the  proposed  design  prevalence  (Cyprus,  Czech 
Republic,  Estonia,  Finland,  Greece,  Hungary,  Latvia,  Lithuania, 
Luxembourg, Malta, Portugal, Slovenia and Slovakia), it would take 
between three and 25 extra years (depending on the MS) to detect that 
yearly increase in prevalence should testing of healthy slaughtered 
cattle be stopped compared to the current testing regime.  
o  Regarding Atypical BSE: 
  Based on a theoretical scenario of an 10% annual increase in the number of 
Atypical BSE infected and detectable cattle in the tested population, the C-
TSEMM model estimates that: 
  In the EU25 as a whole, there is not sufficient data (i.e. number of 
                                                       
26   EFSA (European Food Safety Authority), 2008a. Risk for Human and Animal Health related to the revision of the BSE 
Monitoring regime in some Member States. The EFSA Journal. 762, 1 - 47. 
  EFSA, 2008b. Further considerations of age-related parameters on the Risk for Human and Animal Health related to the 
revision of the BSE Monitoring regime in some Member States. The EFSA Journal, 763, 1-8. 
  EFSA, 2009. Updated risk for human and animal health related to the revision of the BSE monitoring regime in some 
Member States. The EFSA Journal, 1059, 1-40. 
  EFSA, 2010. Opinion of the Scientific Panel on Biological Hazards on a second update on the risk for human and animal 
health related to the revision of the BSE monitoring regime in some Member States. The EFSA Journal, 8(12), 1946. Sample size healthy slaughter cattle BSE monitoring  
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detected  cases  annually)  to  reliably  estimate  the  impact  of  the 
stopping/continuation  of  testing  healthy  slaughtered  animals  older 
than 72 months. 
  However,  using  France  as  an  example  (i.e.  country  with  a  large 
population and sufficient number of detected Atypical cases) the C-
TSEMM model indicates that, based on a theoretical scenario of an 
annual 10% increase of detectable prevalence of Atypical BSE in the 
tested population, it would take an extra 13 years to detect that yearly 
increase in prevalence should testing of healthy slaughtered cattle be 
stopped compared to the current testing regime. 
When interpreting the estimates presented above or those obtained in future simulations performed 
with  the  C-TSEMM  model,  consideration  has  to  be  given  to  the  assumptions,  limitations  and 
uncertainty in the model. Moreover, the models estimates presented in this report are based on the 
demographics of the adult cattle population in 2011 and on the number of adult cattle removed from 
the  population  via  the  different  streams  (i.e.  healthy  slaughter,  animals  showing  clinical  signs  of 
disease during ante mortem inspection, emergency slaughtered animals and fallen stock). Therefore, 
future fluctuations in those numbers at EU level and in each of the MSs will impact the validity of the 
current estimates. 
Thus, should the C-TSEMM model be employed in future years for the review of the BSE monitoring 
regime in the EU, updated yearly data including BSE testing data have to be considered as these drive 
the results estimated by the model. 
5.3.  Estimating  capacity  of  the  BSE  surveillance  system  to  detect  the  emergence  of  an 
hypothetical new type of cattle TSE  
The  model  developed  to  prepare  this  Scientific  Report  allows  for  future  simulations  via  the 
modification of key parameters reflecting the epidemiological behaviour of a TSE in cattle (i.e. the age 
at onset, the age distribution and the sensitivity of current TSE rapid tests). It could therefore serve to 
estimate  through  simulation  the  performance  of  a  defined  surveillance  system  for  detecting  the 
emergence of a hypothetical new type of cattle TSE.  
When elaborating on a possible new form of TSE in cattle, very different situations can be considered. 
Whereas certain situations would be purely hypothetical, other could correspond to features of already 
known TSE agents (e.g. chronic wasting disease (CWD), transmissible mink encephalopathy (TME),  
Classical and Atypical scrapie in small ruminants, Atypical BSE in cattle). 
Amongst the possible scenario to be explored, the following could be included: 
  A moderate to high contagiousness of the disease (e.g. similar to CWD,  Classical scrapie), 
with efficient horizontal transmission during the asymptomatic incubation period. 
  A limited capacity of the test to detect infected and incubating individuals (e.g. similar to 
Atypical Scrapie). 
  A  potentially  long  incubation  asymptomatic  period  (e.g.  similar  Atypical  BSE,  Atypical 
scrapie) by comparison to life expectations of farmed animals.  
Considering  the  timeframe  available  for  this  mandate,  carrying  out  simulation  studies  was  not 
possible. However, the C-TSEMM model developed in parallel to this Scientific Report (Adkin et al., 
2012) can be considered as a useful tool in order to simulate ad hoc epidemiological scenarios of 
hypothetical new types of cattle TSEs. Sample size healthy slaughter cattle BSE monitoring  
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6.  The impact of a new TSE testing policy on TSE monitoring in healthy slaughtered cattle 
with unchanged testing in at risk cattle 
As presented in two previously related EFSA Opinions concerning the first and the second update of 
the BSE monitoring regime (EFSA, 2008a, 2010), currently EU BSE surveillance aims at detecting:  
  Any changes in the trend of the BSE epidemiology, like a decrease or an increase in the 
number of BSE cases per period in a given region, or in a specific cattle subpopulation (young 
animals, old animals). 
  A hypothetical new emerging TSE in cattle, such as Atypical BSE. 
Furthermore, it has to be noted that the main general conclusions of the first Opinion on the revision of 
the BSE monitoring regime in some MSs (EFSA, 2008a) do remain valid in the context of this Report: 
  The  purpose  of  the  TSE  surveillance  in  cattle  in  the  EU  is  mainly  to  monitor  the  BSE 
epidemic. 
  Prevention of human exposure to BSE Agent mainly relies on SRM removal.  
  Prevention of animal exposure to and propagation of TSE Agents mainly relies on the Feed 
Ban. 
The objective of the former EFSA Opinions was to assess the human and animal health consequences 
of modifications to the TSE monitoring system in cattle, including options in which TSE testing would 
be stopped in healthy slaughtered and /or at risk animals born after certain dates. Such scenarios would 
influence the capacity of the EU TSE monitoring system to fulfil these objectives. 
It has to be noted that in the event of a re-emergence of Classical BSE, stopping the testing of healthy 
slaughtered cattle would lower the sensitivity of its detection by the TSE monitoring system. 
The possible future relaxation of certain TSE control measures in cattle and the lack of knowledge 
related to Atypical BSE strongly plead in favour of a continued, although adapted TSE monitoring 
system in cattle, which is in balance with the relaxation of the control measures. 
Other relevant conclusions of those former EFSA Opinions remain also valid, in particular it can be 
noted that: 
  passive  surveillance  on  its  own  cannot  be  considered  an    appropriate  approach  to  TSE 
surveillance, since it leads to late detection, when clinical symptoms are not well known and is 
has a very low sensitivity; 
  targeted testing of the at-risk population could represent an efficient early detection tool for 
the re-emergence of BSE and/or of a new TSE epidemics if it should occur in cattle in the 
future. 
Assuming a new TSE monitoring system in cattle might be designed, aiming at detection of at least 
one TSE case per 100 000 at a confidence level of 95% over a period of 1 year in the adult cattle 
population, this could for example consist of the BSE testing of 100% at-risk cattle over 48 months 
and a minimum sample size in healthy slaughtered cattle above 72 months. In such a situation one may 
also consider the following: 
  the (historic) scientific data and the uncertainties related to TSE in cattle, and 
  the need to ensure a high level of protection towards TSE risks.   Sample size healthy slaughter cattle BSE monitoring  
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Apart from the sample size, another important point to consider in designing a sampling strategy for 
the monitoring and surveillance of TSE in healthy slaughtered cattle is the sampling method, in order 
to ensure the randomness of the sample (probability sampling) in the targeted population. 
If monitoring of BSE in healthy slaughtered cattle remains based on a sample size of animals over 
certain age, then a sampling strategy should be designed in order to ensure randomness in the targeted 
population: in this way the sample drawn will better reflect the characteristics of the target population 
(e.g. in terms of age-, breed-, geographical, feeding regime-, time period-distribution). Stratification 
procedures  may  help  in  sampling  each  subpopulation  (strata,  in  particular  when  they  are  thin) 
independently and therefore improving the representatives of the final sample.  
In the frame of the active surveillance of BSE, the study population is mainly composed of healthy 
slaughter cattle and fallen stock; in this particular situation it is not possible to apply a simple random 
sampling which would require the selection of the sample units by drawing up them from a list, i.e. the 
sampling frame, that is not available by definition. The randomness may be obtained based on the 
animal ranking in the slaughtering chain through a systematic sampling where the first animal is 
selected randomly followed by selection at equal intervals (Duncan and Glen, 2006). This sampling 
strategy therefore does not require knowledge of total size of the study population.  
If probability sampling is not ensured, the presence of sampling biases might modify the estimated 
prevalence of TSEs in the population, in any direction depending on the type of bias, and affect the 
surveillance ability to monitor the TSE trend.  
Concluding remarks on the impact of the TSE testing policy on TSE monitoring in cattle 
  BSE Passive Surveillance has been demonstrated to be a very insensitive detection system, 
when BSE is not expected or easily recognised. 
  In contrast active surveillance has been demonstrated to be a far more effective and more 
sensitive method for BSE monitoring. 
  In the event of a re-emergence of Classical BSE, stopping the testing of healthy slaughtered 
cattle would lower the sensitivity of its detection by the TSE monitoring system. 
  If monitoring of BSE in healthy slaughtered cattle remains based on a sample of animals over 
certain age, then a sampling strategy should be designed in order to ensure randomness in the 
targeted population: in this way the sample drawn will better reflect the characteristics of the 
target population (e.g. in terms of age-, breed-, geographical, feeding regime-, time period-
distribution). Stratification procedures may help in sampling each subpopulation (i.e. strata, in 
particular when they are thin) independently and therefore improving the representatives of 
the final sample.  
  It is recommended to assess the sensitivity of the EU surveillance system for detecting the 
prevalence and trend of Atypical BSE, re-emergence of  Classical BSE and the emergence of 
an hypothetical new type of TSE in cattle should changes be made to current EU BSE control 
measures and in particular to the total feed ban. This assessment should take into account that, 
at least for feed-borne transmitted TSEs like Classical BSE, the impact of potential changes to 
the current total feed ban, it will most likely take five or more years to become apparent due to 
the known incubation period for Classical BSE, whereas control measures related to the feed 
ban are likely not to have any influence on non-feed related TSE cases.  
 
 Sample size healthy slaughter cattle BSE monitoring  
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CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
General Conclusions 
  A constant decline in the total number of detected BSE cases (i.e. coming from both Active 
and Passive surveillance) has been recorded in the EU 17 group of MSs (Austria, Belgium, 
Cyprus,  Denmark,  Finland,  France,  Germany,  Greece,  Ireland,  Italy,  Luxembourg, 
Netherlands, Portugal, Slovenia, Spain, Sweden and United Kingdom)  from 2 157 cases in 
2001 to 27 cases in 2011. BSE has not been detected in 5 MSs of the EU8 group of MSs (the 
EU5 group: Estonia, Hungary, Latvia, Lithuania and Malta).  In 3 MSs of the EU8 group (the 
EU3 group: Czech Republic, Poland and Slovakia), the number of detected cases dropped 
down  from 28 in 2005 (peak) to one in 2011. 
  The log10 transformed annual BSE prevalence and incidence (defined respectively as the 
number of positive BSE cases out of the tested population and out of the standing adult cattle 
population) in the  EU17 and in the EU8 show a statistically significant decreasing trend. 
There has been a statistically significant increasing trend in the average age of the detected 
BSE cases per test year during the last 11 years and eight years in the EU17 and the EU8, 
respectively.  At  present,  this  average  age  exceeds  11  years  in each  of these MSs  (where 
reported in 2011).  
  Assuming that the age distribution of cattle within the EU25 has not changed substantially, the 
decreasing trend observed in the annual BSE occurrence and the increasing trend observed in 
the annual average age of the cases are the consequence of the implementation of the BSE 
control measures.  
  Epidemiological data reported by the EU MSs indicate that over the last years the number of 
detected Atypical BSE cases did not show any trend and that Atypical BSE cases were mainly 
identified in the fallen stock and healthy slaughtered animals older than eight years of age.  
  The  performance  of  the  current  BSE  monitoring  system,  both  in  terms  of  its  analytical 
sensitivity and earliness of the detection of animals infected with Atypical BSE is unknown.  
Reply to the Terms of Reference 
In  order  to  support  the  quantitative  reply  to  the  terms  of  reference,  a  model  called  Cattle  TSE 
Monitoring Model (C-TSEMM) was developed by an EFSA contractor in order to provide a general 
frame for evaluating the design prevalence and the sensitivity of cattle TSE monitoring systems
27. 
This model, so called Cattle TSE Monitoring Model (C -TSEMM), has a series of assumptions that 
have to be considered when interpreting the estimates provided by this. Among those assumptions, a 
key one is that for MSs with no, or few, BSE cases post-2001 an alternative estimate of cohort-based 
prevalence is required. This has been estimated for those MSs based on the average prevalence of the 
group of MSs with BSE cases under which they were placed in previous EFSA Opinions
28: the EU17 
                                                       
27  Amie  Adkin,  Robin  Simmons  and  Mark  Arnold;  Model  for  evaluation  of  different  options  for  the  monitoring  of 
Transmissible  Spongiform  Encephalopathies  in  cattle  in  the  European  Union  (C-TSEMM).  Supporting  Publications 
2012:EN-349. [55 pp.]. Available online: www.efsa.euopa.eu/publications 
28 EFSA, 2010. Opinion of the Scientific Panel on Biological Hazards on a second update on the risk for human and animal 
health related to the revision of the BSE monitoring regime in some Member States. The EFSA Journal, 8(12), 1946. Sample size healthy slaughter cattle BSE monitoring  
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or the EU8 group
29. This results in an overestimate of prevalence for countries with no recorded cases 
as they are assumed to be a merged epidemiological unit with MSs where cases are observed. 
Based on the estimates provided by  the C-TSEMM model  that  considered  prevalence  in  the 
standing adult cattle population (i.e. period prevalence in a given year of detectable infected 
animals  in  the  standing  population)  and  the  available  historical  EU  wide  data  on  BSE 
monitoring, the following provides support to the reply of the quantitative aspects of the request 
received from the European Commission: 
  With regards to the request for a proposal on a minimum annual sample size in healthy 
slaughtered cattle above 72 months of age in order to allow the detection of BSE with a 
yearly design prevalence of at least 1 case per 100 000 in the adult population (i.e. older 
than 24 months of age) of the Member States, at a confidence level of 95% in the group of 25 
EU Member States as a whole and in each Member State individually. 
o  In the EU25 as a whole and according to C-TSEMM model estimates: 
  The current BSE monitoring regime enables the detection of one BSE case in 
6 354 930 adult cattle with a confidence level of 95%.  
  If  the  current  BSE  monitoring  regime  would  exclude  testing  of  healthy 
slaughter cattle, it would be able to detect in the standing population one BSE 
case in 4 021 940  adult cattle with a confidence level of 95%. Therefore, no 
healthy  slaughter  animals  need  to  be  tested  in  order  to  meet  a  design 
prevalence of 1 detectable case in 100 000 adult cattle, since testing of at risk 
animals (i.e. animals showing clinical signs during ante mortem inspection, 
emergency slaughter and fallen stock over 48 months of age, and clinical 
suspects) is sufficient to meet the proposed design prevalence.  
o  At individual MS level, according to C-TSEMM model estimates: 
  In  eight  MSs (Belgium,  Denmark,  France,  Germany,  Ireland,  Netherlands, 
Spain and the UK) the testing of healthy slaughter animals is not needed in 
order to meet a 1 in 100 000 design prevalence with a confidence level of 
95%, since testing of at risk animals is sufficient to meet the proposed design 
prevalence.    
  In four MSs (Austria, Italy, Poland and Sweden) the testing of a fraction of 
healthy slaughtered animals older than 72 months of age (i.e. on the basis of 
the number tested in 2011) would be sufficient to meet a 1 in 100 000 design 
prevalence with a confidence level of 95%. 
  In thirteen MSs (Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, 
Latvia, Lithuania, Luxembourg, Malta, Portugal, Slovenia and Slovakia) the 
number of tested animals in 2011 (i.e. including all the healthy slaughtered 
animals older than 72 months of age) did not allow to meet a 1 in 100 000 
design prevalence with 95% confidence. However, fitting a sample size larger 
than the actually slaughtered cattle population of a MS is neither feasible nor 
realistic. Thus, the current testing of all animals of certain age categories that 
are  slaughtered  or  dead  may  provide  the  most  sensitive  BSE  monitoring 
system  possible  (i.e.  that  employs  post  mortem  tests)  under  the  current 
epidemiological scenario with the potential limitation on the impact of the age 
                                                       
29 EU17: Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, 
Portugal, Slovenia, Spain, Sweden and United Kingdom;  EU8:  Czech Republic, Estonia, Hungary, Latvia,  Lithuania, 
Malta, Poland and Slovakia Sample size healthy slaughter cattle BSE monitoring  
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at testing as evaluated in former related EFSA Opinions
30. 
  On the added value of this minimum sample to the overall surveillance programme in terms 
of monitoring the trend of  Classical BSE, Atypical BSE and the emergence of an hypothetical 
new type of cattle TSE: 
o  Regarding  Classical BSE: 
  In  the  event  of  a  re-emergence  of  Classical  BSE,  stopping  the  testing  of 
healthy slaughtered cattle would lower the sensitivity of its detection by the 
TSE monitoring system. 
  Based on a theoretical scenario of an annual 10% increase in detectable cases 
in the tested population (prevalence), the C-TSEMM model estimates that: 
  In  the  EU25  as  a  whole,  where  testing  healthy  slaughtered  cattle 
above  and  age  of  72  months  is  not  needed  in  order  to  meet  the 
proposed design prevalence, the time to detection of the supposed 
10% yearly increase in detectable cases would increase from six to  
11 years ( i.e. five extra years to detect the supposed 10% yearly 
increase in prevalence of detectable cases) should testing of healthy 
slaughtered cattle be stopped compared to the current testing regime. 
  In those MSs where testing healthy slaughtered cattle above the age 
of  72  months  is  not  needed  in  order to  meet the proposed  design 
prevalence  (Belgium,  Denmark,  France,  Germany,  Ireland, 
Netherlands,  Spain and  the  UK), it  would take  between  three and 
eight extra years (depending on the MS) to detect that yearly increase 
in prevalence should testing of healthy slaughtered cattle be stopped 
compared to the current testing regime. 
  In  those  MSs  where  testing  healthy  slaughtered  cattle  could  be 
reduced in order to meet the proposed design prevalence (Austria, 
Italy, Poland and Sweden), it would take between six and 16 extra 
years  (depending  on  the  MS)  to  detect  that  yearly  increase  in 
prevalence should testing of healthy slaughtered cattle older than 72 
months of age be reduced to the number needed to meet the proposed 
design prevalence compared to the current testing regime. 
  In those MSs where testing healthy slaughtered cattle older than 72 
months  of  age  as  per  the  current  BSE  monitoring  regime  is  not 
sufficient  to  meet  the  proposed  design  prevalence  (Cyprus,  Czech 
Republic,  Estonia,  Finland,  Greece,  Hungary,  Latvia,  Lithuania, 
Luxembourg, Malta, Portugal, Slovenia and Slovakia), it would take 
between three and 25 extra years (depending on the MS) to detect that 
yearly increase in prevalence should testing of healthy slaughtered 
cattle be stopped compared to the current testing regime.   
                                                       
30   EFSA (European Food Safety Authority), 2008a. Risk for Human and Animal Health related to the revision of the BSE 
Monitoring regime in some Member States. The EFSA Journal. 762, 1 - 47. 
  EFSA, 2008b. Further considerations of age-related parameters on the Risk for Human and Animal Health related to the 
revision of the BSE Monitoring regime in some Member States. The EFSA Journal, 763, 1-8. 
  EFSA, 2009. Updated risk for human and animal health related to the revision of the BSE monitoring regime in some 
Member States. The EFSA Journal, 1059, 1-40. 
  EFSA, 2010. Opinion of the Scientific Panel on Biological Hazards on a second update on the risk for human and animal 
health related to the revision of the BSE monitoring regime in some Member States. The EFSA Journal, 8(12), 1946. Sample size healthy slaughter cattle BSE monitoring  
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o  Regarding Atypical BSE: 
  Based on a theoretical scenario of an 10% annual increase in the number of 
Atypical BSE infected and detectable cattle in the tested population, the C-
TSEMM model estimates that: 
  At  EU25  as  a  whole,  there  is  not  sufficient  data  (i.e.  number  of 
detected  cases  annually)  to  reliably  estimate  the  impact  of  the 
stopping/continuation  of  testing  healthy  slaughtered  animals  older 
than 72 months. 
  However,  using  France  as  an  example  (i.e.  country  with  a  large 
population and sufficient number of detected Atypical cases) the C-
TSEMM model indicates that, based on a theoretical scenario of an 
annual 10% increase of detectable prevalence of Atypical BSE in the 
tested population, it would take an extra 13 years to detect that yearly 
increase in prevalence should testing of healthy slaughtered cattle be 
stopped compared to the current testing regime. 
o  Regarding an hypothetical new type of cattle TSE: 
  Considering the timeframe available for this mandate, carrying out 
simulation studies for hypothetical new types of cattle TSEs was not 
possible. However, the C-TSEMM model developed in parallel to this 
Scientific  Report  can  be  considered  as  a  useful  tool  in  order  to 
simulate future ad hoc epidemiological scenarios of hypothetical new 
types of cattle TSEs. 
When interpreting the estimates presented above or those obtained in future simulations performed 
with  the  C-TSEMM  model,  consideration  has  to  be  given  to  the  assumptions,  limitations  and 
uncertainty in the model. Moreover, the models estimates presented in this report are based on the 
demographics of the adult cattle population in 2011 and on the number of adult cattle removed from 
the  population  via  the  different  streams  (i.e.  healthy  slaughter,  animals  showing  clinical  signs  of 
disease during ante mortem inspection, emergency slaughtered animals and fallen stock). Therefore, 
future fluctuations in those numbers at EU level and in each of the MSs will impact the validity of 
current estimates. 
RECOMMENDATIONS 
The following is recommended: 
  If monitoring of BSE in healthy slaughtered cattle remains based on a sample of animals over 
certain age, then a sampling strategy should be designed in order to ensure randomness in the 
targeted population: in this way the sample drawn will better reflect the characteristics of the 
target population (e.g. in terms of age-, breed-, geographical, feeding regime-, time period-
distribution). Stratification procedures may help in sampling each subpopulation (i.e. strata, in 
particular when they are thin) independently and therefore improving the representatives of 
the final sample.  
  To assess the sensitivity of the EU surveillance system for detecting the prevalence and trend 
of Atypical BSE, re-emergence of  Classical BSE and the emergence of an hypothetical new 
type of TSE in cattle should changes be made to current EU BSE control measures and in 
particular to the total feed ban. This assessment should take into account that, at least for feed-
borne transmitted TSEs like Classical BSE, the impact of potential changes to the current total 
feed ban  will  most  likely  take  five  or  more  years to  become  apparent  due to  the  known Sample size healthy slaughter cattle BSE monitoring  
 
EFSA Journal 2012;10(10):2913  54 
incubation period for Classical BSE, whereas control measures related to the feed ban are 
likely not to have any influence on non-feed related TSE cases. 
  Should  the  C-TSEMM  model  be  employed  in  future  years  for  the  review  of  the  BSE 
monitoring regime in the EU, updated yearly data including BSE testing data have to be 
considered as these drive the results estimated by the model. 
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APPENDICES 
A.  SUMMARY TABLES ON THE REVIEW OF THE BSE TREND IN THE 25 EU MSS BY GROUP OF MSS 
Data excludes cases with unidentified age category. Details are presented in Table 1 below. 
Table 14:   Reported BSE cases by MS that were excluded from the analysis due to incomplete data 
on age category or year of testing.  
MSs 
Year of testing 
1991  2003  2004  2005  2006  2007  2008 
Belgium  1
*             
Portugal    1  1        1 
United Kingdom      2  3  2  4   
         *Reported year of testing 1991 is the reason for exclusion from the analysis.  
 
 
 
1. Group of 17 EU MSs (EU17). 
Table 15:   Prevalence (number of BSE cases per ten thousand of animals tested) of BSE in the EU17 
for passive and active surveillance from 2001 to 2011. Prevalence for some years presented in this 
table may be slightly different to those presented in the EFSA Scientific Opinion of 2010 (EFSA, 
2010) due to changes made by MSs to the reported data hosted by the European Commission.  
Type of testing 
Year of testing 
2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
Active Surveillance  1.23  1.38  1.01  0.64  0.49  0.31  0.16  0.12  0.09  0.06  0.05 
Passive Surveillance  3086  2535  1165  571  256  161  83  51  29  0  0 
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Table 16:   Number of BSE cases detected through the BSE Surveillance (Active and Passive) in 
EU17 during the period 2001 – 2011 per birth cohort and year of detection.  
Birth cohort 
N
o of detected BSE cases per year 
2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011  Grand Total 
1980     1                             1 
1981  1                          1     2 
1982                        0 
1983        1                          1 
1984  1  3           1                 5 
1985  1  2  2     1                    6 
1986  13  10  3  3  1                    30 
1987  21  30  9  6  6  1     1           74 
1988  20  28  21  8     1     2        1  81 
1989  25  37  21  17  5  5  1  1  1        113 
1990  28  54  22  22  9  7  1  3  1        147 
1991  66  78  47  27  22  8  1  1     1  1  252 
1992  120  156  84  55  37  15  10  1  2     1  481 
1993  328  245  180  95  56  27  17  9  6  4  2  969 
1994  577  457  218  123  91  48  25  16  6  3  3  1 567 
1995  665  615  300  137  66  37  22  10  11  6  3  1 872 
1996  243  269  163  79  37  25  9  23  5  5  2  860 
1997  44  90  152  85  34  23  6  13  4  5  4  460 
1998  4  29  73  94  40  32  17  7  5  2  4  307 
1999     5  24  50  57  36  15  9  5  5  2  208 
2000        1  19  49  35  19  8  6  4  3  144 
2001              7  8  2  5  1  1     24 
2002              2  1  3  3  2        11 
2003                       3  3        6 
2004                          1  4     5 
2005                                1  1 
Grand Total  2 157  2 109  1 321  820  520  310  148  115  59  41  27  7 627 
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Table 17:   Number of BSE cases, incidence per million adult cattle (i.e. over 24 months of age) and 
average age in years of cases during the period 2001 – 2011 per year of detection in the EU17 MS. 
The data consider both BSE Active and Passive Surveillance. 
Member 
State  
   Year of testing  Total 
   2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
   N° cases  1  0  0  0  2  2  1  0  0  2  0  8 
Austria   Incidence  1.0  0  0  0  2.1  2.1  1.1  0  0  2.1  0       Average age  5.0  NA   NA  NA  12.0  9.5  11.0  NA  NA  14.0  NA  10.9 
   N° cases  45  38  15  11  3  1  0  0  0  0  0  113 
Belgium   Incidence  29.7  26.1  10.6  7.8  2.2  0.7  0  0  0  0  0       Average age  6.0  6.7  7.4  7.5  10.0  12.0  NA   NA  NA  NA  NA  6.7 
   N° cases  0  0  0  0  0  0  0  0  0  0  0  0 
Cyprus   Incidence  0  0  0  0  0  0  0  0  0  0  0       Average age  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA 
   N° cases  6  3  2  1  1  0  0  0  1  0  0  14 
Denmark   Incidence  6.7  3.5  2.4  1.3  1.3  0  0  0  1.3  0  0   
   Average age  5.0  5.3  6.5  14.0  9.0   NA  NA  NA  14.0  NA  NA  6.9 
   N° cases  1  0  0  0  0  0  0  0  0  0  0  1 
Finland   Incidence  2.4  0  0  0  0  0  0  0  0  0  0   
   Average age  6   NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  6 
   N° cases  274  239  111  51  32  8  7  8  10  5  3  748 
France   Incidence  24.7  21.8  10.4  4.9  3.1  0.8  0.7  0.8  0.9  0.5  0.3       Average age  6.4  7.2  8.1  8.8  9.4  9.3  10.7  12.4  13.6  11.6  14.3  7.5 
   N° cases  121  103  53  63  32  16  4  2  2  0  0  396 
Germany   Incidence  18.8  16.5  8.6  10.5  5.5  2.8  0.7  0.3  0.3  0  0   
   Average age  5.5  6.4  5.9  6.2  6.2  7.0  7.8  8.0  11.0  NA   NA  6.1 
   N° cases  1  0  0  0  0  0  0  0  0  0  0  1 
Greece   Incidence  3.0  0  0  0  0  0  0  0  0  0  0   
   Average age  5.0  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  5.0 
   N° cases  242  329  182  125  73  38  25  20  9  2  3  1 048 
Ireland   Incidence  79.5  109.4  60.8  41.0  23.8  12.6  8.5  7.3  3.2  0.7  1.1       Average age  6.6  7.8  8.7  9.8  10.1  11.1  11.6  11.8  11.2  15.0  16.7  8.4 
   N° cases  50  36  31  7  8  7  2  1  2  0  1  145 
Italy   Incidence  15.5  11.9  10.4  2.4  2.7  2.5  0.7  0.4  0.7  0  0.4       Average age  5.6  6.5  7.8  7.3  8.1  8.3  12.5  13.0  12.0  NA   14.0  6.9 
   N° cases  0  1  0  0  1  0  0  0  0  0  0  2 
Luxemburg  Incidence  0  10.3  0  0  10.8  0  0  0  0  0  0       Average age  NA
2  6.0  NA  NA  4.0  NA  NA  NA  NA  NA  NA  5.0 
   N° cases  20  24  18  6  3  2  2  1  0  3  0  79 
Netherlands   Incidence  11.2  13.5  10.1  3.5  1.8  1.2  1.2  0.6  0  1.7  0   
   Average age  6.3  6.2  6.7  8.3  4.7  8.5  7.5  8.0     12.7     6.8 
   N° cases  110  85  132  89  53  32  13  18  6  5  5  548 
Portugal   Incidence  142.2  109.3  168.8  109.5  64.4  39.2  15.7  21.7  7.1  5.8  5.9   
   Average age  6.7  7.3  7.7  8.6  9.7  10.9  11.4  12.6  13.3  15.4  16.4  8.4 
   N° cases  1  1  1  2  1  1  1  0  0  0  0  8 
Slovenia   Incidence  4.7  4.6  4.8  9.9  5.1  5.1  4.9  0  0  0  0       Average age  5.0  7.0  4.0  5.0  5.0  6.0  7.0              5.5 
   N° cases  82  127  166  137  98  76  32  24  18  13  7  780 
Spain   Incidence  23.8  35.8  46.3  38.2  28.2  23.8  9.5  7.4  5.5  4.0  2.3   
   Average age  6.4  6.5  6.8  6.8  6.7  7.5  9.1  10.2  12.4  11.8  13.0  7.2 
   N° cases  0  0  0  0  0  1  0  0  0  0  0  1 
Sweden   Incidence  0  0  0  0  0  1.5  0  0  0  0  0   
   Average age  NA   NA  NA  NA  NA  12.0  NA  NA  NA  NA  NA  12.0 
United 
Kingdom  
N° cases  1 203  1 123  610  328  213  126  61  41  11  11  8  3 735 
Incidence  243.7  228.3  124.7  66.7  43.5  25.8  12.8  8.8  2.4  2.4  1.8    Average age  7.6  8.9  9.6  10.7  11.4  11.8  11.9  12.6  11.8  14.3  14.8  9.1 
   N° cases  2 157  2 109  1 321  820  520  310  148  115  59  41  27  7 627 
EU17  Incidence  53.9  53.6  34.0  21.4  13.7  8.3  3.9  3.1  1.6  1.1  0.7       Average age  7.0  8.1  8.6  9.1  9.6  10.1  10.9  11.8  12.4  13.2  14.7  8.4 
1NA=Non Applicable 
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2. Group of 8 EU MSs (EU8). 
Table 18:   Prevalence (number of BSE cases per ten thousand of animals tested) of BSE in the EU3 
(i.e. where BSE cases have been reported) and in the EU8 for active surveillance from 2004 to 2011. 
No cases have been identified through passive surveillance in the EU3.  
Prevalence  Year of testing 
2004  2005  2006  2007  2008  2009  2010  2011 
EU3  0.33  0.37  0.15  0.16  0.07  0.07  0.04  0.02 
EU8  0.26  0.28  0.12  0.12  0.06  0.05  0.03  0.01 
 
Table 19:   Number of BSE cases detected through the BSE Surveillance (Active and Passive) in EU3 
(i.e. where BSE cases have been reported) during the period 2004 – 2011 per birth cohort and year of 
detection.  
  
Birth Cohort 
No of detected BSE cases per year   
2004  2005  2006  2007  2008  2009  2010  2011  Total 
1992  2  1                    3 
1993                  0 
1994  1  1  2                 4 
1995  3  1  1  3     1  1     10 
1996  5  2  3  1           1  12 
1997  2  2  1                 5 
1998  3  2  1  1              7 
1999  2  5  2  3  2  2        16 
2000  5  11  2  1  1  1  1     22 
2001  2  2  1  2  1           8 
2002     1              1     2 
2003           1  1  1        3 
2004           1     1        2 
2005              1           1 
Grand Total  25  28  13  13  6  6  3  1  95 
1 In 2004, seven cases were diagnosed before 1
st May. 
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Table 20:   Number of BSE cases, incidence per million cattle over 24 months and average age in 
years of cases during the period 2004 – 2011 per year of detection in the EU8 MS (the data consider 
both BSE Active and Passive Surveillance. Please note no cases identified in Passive Surveillance). 
Member 
State  
   Year of testing  Total 
   2004  2005  2006  2007  2008  2009  2010  2011 
  
Czech 
Republic  
N° cases  7  7  3  2  0  2  0  0  21 
Incidence  10.7  10.9  4.6  3.1  0  3.1  0  0   
Average age  5.9  5.1  6.3  10  NA   5.5  NA  NA  6.0 
   N° cases  0  0  0  0  0  0  0  0  0 
Estonia  Incidence  0  0  0  0  0  0  0  0   
   Average age  NA  NA  NA  NA  NA  NA  NA  NA  NA 
   N° cases  0  0  0  0  0  0  0  0  0 
Hungary  Incidence  0  0  0  0  0  0  0  0   
   Average age  NA  NA  NA  NA  NA  NA  NA  NA  NA 
   N° cases  0  0  0  0  0  0  0  0  0 
Latvia  Incidence  0  0  0  0  0  0  0  0   
   Average age  NA  NA  NA  NA  NA  NA  NA  NA  NA 
   N° cases  0  0  0  0  0  0  0  0  0 
Lithuania  Incidence  0  0  0  0  0  0  0  0   
   Average age  NA  NA  NA  NA  NA  NA  NA  NA  NA 
   N° cases  0  0  0  0  0  0  0  0  0 
Malta  Incidence  0  0  0  0  0  0  0  0   
   Average age  NA  NA  NA  NA  NA  NA  NA  NA  NA 
   N° cases  11  19  10  9  5  4  2  1  61 
Poland  Incidence  3.6  6.2  3.3  3.0  1.6  1.3  0.7  0.3   
   Average age  8.3  6.9  9.4  8.2  6.8  10.8  12.5  15.0  8.3 
   N° cases  7  2  0  2  1  0  1  0  13 
Slovakia  Incidence  25.9  7.4  0  7.9  4.0  0  4.1  0   
   Average age  5.3   5.0  NA  6.0  7.0  NA   8.0  NA    
   N° cases  25  28  13  13  6  6  3  1  95 
EU8  Incidence  4.8  5.4  2.6  2.6  1.2  1.2  0.6  0.2   
   Average age  6.8  6.4  8.7  8.2  6.8  9.0  11.0  15.0  7.5 
1 In 2004, seven cases were diagnosed before 1
st May. 
2 NA=Non applicable. 
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B.  BSE  CASES  DETECTED  THROUGH  BSE  MONITORING  (ACTIVE  AND  PASSIVE)  BETWEEN 
2001/2004 AND 2011 PER MEMBER STATE, BIRTH COHORT AND YEAR OF DETECTION 
The following has to be considered when interpreting the data provided in this Appendix: 
  Data as provided by the European Commission on 3 July 2012. 
  Data excludes cases identified in the frame of BSE eradication measures. Details are presented 
in Table 1 below. 
Table 21:   Reported BSE cases identified in the frame of BSE eradication measures in the EU from 
2001 to 2011. 
MSs 
N
o of detected BSE cases per year
1 
Total   2001  2002  2003  2004  2005  2006  2007  2008 
Belgium  1                1 
Czech Republic 
        1        1 
France  3  1              4 
Germany  4  3  1  2          10 
Ireland 
  5  1  1        2  9 
Poland 
        1        1 
Portugal 
  1    2          3 
Slovakia 
        1        1 
Spain  1    1    5    1    8 
United Kingdom 
        8  1    1  10 
Total  9  10  3  5  16  1  1  3  48 
            1No cases identified in the frame of BSE eradication measures have been reported after 2008 up to 2011. 
 
  Data excludes cases with unidentified age category. Details are presented in Table 2 below. 
Table 22:   Reported BSE cases by MS that were excluded from the analysis due to incomplete data 
on age category or year of testing.  
MSs 
Year of testing 
1991  2003  2004  2005  2006  2007  2008 
Belgium  1
*             
Portugal    1  1        1 
United Kingdom      2  3  2  4   
         *Reported year of testing 1991 is the reason for exclusion from the analysis.  
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Austria (AT) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Austria 
since 2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  -  -  -  0 
1991  -  -  -  -  -  -  -  -  -  -  -  0 
1992  -  -  -  -  1  -  -  -  -  -  -  1 
1993  -  -  -  -  -  1  -  -  -  -  -  1 
1994  -  -  -  -  1  -  -  -  -  -  -  1 
1995  -  -  -  -  -  -  -  -  -  1  -  1 
1996  1  -  -  -  -  -  1  -  -  -  -  2 
1997  -  -  -  -  -  -  -  -  -  1  -  1 
1998  -  -  -  -  -  -  -  -  -  -  -  0 
1999  -  -  -  -  -  -  -  -  -  -  -  0 
2000  -  -  -  -  -  1  -  -  -  -  -  1 
2001  -  -  -  -  -  -  -  -  -  -  -  0 
2002  -  -  -  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  -  -  -  0 
2005  -  -   -  -   -  -   -  -   -  -   -  0 
Total  1  0   0   0   2  2  1  0   0   2  0   8 
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Belgium (BE) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Belgium 
since 2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  -  -  -  0 
1991  1  -  1  -  1  -  -  -  -  -  -  3 
1992  1  3  -  -  -  -  -  -  -  -  -  4 
1993  1  1  -  -  -  -  -  -  -  -  -  2 
1994  7  5  2  1  -  1  -  -  -  -  -  16 
1995  17  8  2  -  -  -  -  -  -  -  -  27 
1996  18  13  6  4  -  -  -  -  -  -  -  41 
1997  -  8  3  4  2  -  -  -  -  -  -  17 
1998  -  -  1  2  -  -  -  -  -  -  -  3 
1999  -  -  -  -  -  -  -  -  -  -  -  0 
2000  -  -  -  -  -  -  -  -  -  -  -  0 
2001  -  -  -  -  -  -  -  -  -  -  -  0 
2002  -  -  -  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  -  -  -  0 
Total  45  38  15  11  3  1  0   0   0   0   0   113 
 
 
 
 
 Sample size healthy slaughter cattle BSE monitoring  
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Cyprus (CY) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Cyprus 
since 2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010   2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  -  -  -  0 
1991  -  -  -  -  -  -  -  -  -  -  -  0 
1992  -  -  -  -  -  -  -  -  -  -  -  0 
1993  -  -  -  -  -  -  -  -  -  -  -  0 
1994  -  -  -  -  -  -  -  -  -  -  -  0 
1995  -  -  -  -  -  -  -  -  -  -  -  0 
1996  -  -  -  -  -  -  -  -  -  -  -  0 
1997  -  -  -  -  -  -  -  -  -  -  -  0 
1998  -  -  -  -  -  -  -  -  -  -  -  0 
1999  -  -  -  -  -  -  -  -  -  -  -  0 
2000  -  -  -  -  -  -  -  -  -  -  -  0 
2001  -  -  -  -  -  -  -  -  -  -  -  0 
2002  -  -  -  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  -  -  -  0 
Total  0  0  0  0  0  0  0  0  0  0  0  0 
 
 
 
 
 Sample size healthy slaughter cattle BSE monitoring  
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Czech Republic (CZ) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Czech 
Republic since 2004 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year   
2004  2005  2006  2007  2008  2009  2010  2011  Total 
1980  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  0 
1991  -  -  -  -  -  -  -  -  0 
1992  -  -  -  -  -  -  -  -  0 
1993  -  -  -  -  -  -  -  -  0 
1994  -  -  -  -  -  -  -  -  0 
1995  -  -  -  -  -  -  -  -  0 
1996  1  -  -  1  -  -  -  -  2 
1997  2  -  -  -  -  -  -  -  2 
1998  1  -  -  1  -  -  -  -  2 
1999  1  1  1  -  -  -  -  -  3 
2000  2  6  2  -  -  -  -  -  10 
2001  -  -  -  -  -  -  -  -  0 
2002  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  1  -  -  1 
2004  -  -  -  -  -  1  -  -  1 
2005  -  -  -  -  -  -  -  -  0 
Total  7  7  3  2  0  2  0  0  21 Sample size healthy slaughter cattle BSE monitoring  
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Denmark (DK) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Denmark 
since 2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  -  -  -  0 
1990  -  -  -  1  -  -  -  -  -  -  -  1 
1991  -  -  -  -  -  -  -  -  -  -  -  0 
1992  -  -  -  -  -  -  -  -  -  -  -  0 
1993  1  -  -  -  -  -  -  -  -  -  -  1 
1994  -  -  -  -  -  -  -  -  -  -  -  0 
1995  -  -  -  -  -  -  -  -  1  -  -  1 
1996  3  2  1  -  1  -  -  -  -  -  -  7 
1997  1  -  1  -  -  -  -  -  -  -  -  2 
1998  1  1  -  -  -  -  -  -  -  -  -  2 
1999  -  -  -  -  -  -  -  -  -  -  -  0 
2000  -  -  -  -  -  -  -  -  -  -  -  0 
2001  -  -  -  -  -  -  -  -  -  -  -  0 
2002  -  -  -  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  -  -  -  0 
Total  6  3  2  1  1  0  0  0  1  0  0  14 Sample size healthy slaughter cattle BSE monitoring  
 
EFSA Journal 2012;10(10):2913  70 
Estonia (EE) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Estonia 
since 2004 per birth cohort and year of detection. 
 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2004  2005  2006  2007  2008  2009  2010   2011 
1980  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  0 
1991  -  -  -  -  -  -  -  -  0 
1992  -  -  -  -  -  -  -  -  0 
1993  -  -  -  -  -  -  -  -  0 
1994  -  -  -  -  -  -  -  -  0 
1995  -  -  -  -  -  -  -  -  0 
1996  -  -  -  -  -  -  -  -  0 
1997  -  -  -  -  -  -  -  -  0 
1998  -  -  -  -  -  -  -  -  0 
1999  -  -  -  -  -  -  -  -  0 
2000  -  -  -  -  -  -  -  -  0 
2001  -  -  -  -  -  -  -  -  0 
2002  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  0 
Total  0  0  0  0  0  0  0  0  0 
 
 Sample size healthy slaughter cattle BSE monitoring  
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Finland (FI) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Finland 
since 2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  -  -  -  0 
1991  -  -  -  -  -  -  -  -  -  -  -  0 
1992  -  -  -  -  -  -  -  -  -  -  -  0 
1993  -  -  -  -  -  -  -  -  -  -  -  0 
1994  -  -  -  -  -  -  -  -  -  -  -  0 
1995  1  -  -  -  -  -  -  -  -  -  -  1 
1996  -  -  -  -  -  -  -  -  -  -  -  0 
1997  -  -  -  -  -  -  -  -  -  -  -  0 
1998  -  -  -  -  -  -  -  -  -  -  -  0 
1999  -  -  -  -  -  -  -  -  -  -  -  0 
2000  -  -  -  -  -  -  -  -  -  -  -  0 
2001  -  -  -  -  -  -  -  -  -  -  -  0 
2002  -  -  -  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  -  -  -  0 
Total  1  0  0  0  0  0  0  0  0  0  0  1 
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France (FR) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in France 
since 2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  -  -  -  0 
1986  -  -  -  1  -  -  -  -  -  -  -  1 
1987  -  -  1  -  -  -  -  -  -  -  -  1 
1988  -  1  -  -  -  -  -  -  -  -  -  1 
1989  -    1  -  -  -  -  -  -  -  -  1 
1990  -  1  1  -  1  -  -  1  -  -  -  4 
1991  -  3  2  -  -  -  -  -  -  -  -  5 
1992  1  5  2  2  2  -  -  -  1  -  -  13 
1993  29  17  7  4  3  1  -  2  2  -  -  65 
1994  87  56  23  12  6  2  -  -  -  -  -  186 
1995  132  102  41  10  7  -  3  -  2  2  1  300 
1996  21  40  13  10  2  -  1  2  2  -  1  92 
1997  4  10  16  4  3  2  1  1  1  1  -  43 
1998  -  4  4  6  -  -  2  -  1  -  -  17 
1999  -  -  -  2  5  2  -  -  1  -  1  11 
2000  -  -  -  -  3  -  -  2  -  -  -  5 
2001  -  -  -  -  -  1  -  -  -  1  -  2 
2002  -  -  -  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  -  1  -  1 
2005  -  -  -  -  -  -  -  -  -  -  -  0 
Total  274  239  111  51  32  8  7  8  10  5  3  748 
 
 
 
 
 
 Sample size healthy slaughter cattle BSE monitoring  
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Germany (DE) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Germany 
since 2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  -  -  -  0 
1987  -  1  -  -  -  -  -  -  -  -  -  1 
1988  -  -  -  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  -  -  -  0 
1990  1  1  -  -  -  -  -  -  -  -  -  2 
1991  1  -  -  1  -  -  -  -  -  -  -  2 
1992  1  1  -  -  -  -  -  -  -  -  -  2 
1993  -  3  -  -  -  -  -  -  -  -  -  3 
1994  8  5  -  2  -  -  -  -  -  -  -  15 
1995  40  32  8  2  1  1  -  -  -  -  -  84 
1996  63  43  12  7  3  -  -  -  1  -  -  129 
1997  5  10  13  14  1  -  -  -  -  -  -  43 
1998  2  7  8  9  5  1  -  -  -  -  -  32 
1999  -  -  12  18  11  9  3  -  -  -  -  53 
2000  -  -  -  10  9  5  1  2  1  -  -  28 
2001  -  -  -  -  2  -  -  -  -  -  -  2 
2002  -  -  -  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  -  -  -  0 
Total  121  103  53  63  32  16  4  2  2  0  0  396 
 
 
 
 
 
 Sample size healthy slaughter cattle BSE monitoring  
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Greece (EL) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Greece 
since 2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  -  -  -  0 
1991  -  -  -  -  -  -  -  -  -  -  -  0 
1992  -  -  -  -  -  -  -  -  -  -  -  0 
1993  -  -  -  -  -  -  -  -  -  -  -  0 
1994  -  -  -  -  -  -  -  -  -  -  -  0 
1995  -  -  -  -  -  -  -  -  -  -  -  0 
1996  1  -  -  -  -  -  -  -  -  -  -  1 
1997  -  -  -  -  -  -  -  -  -  -  -  0 
1998  -  -  -  -  -  -  -  -  -  -  -  0 
1999  -  -  -  -  -  -  -  -  -  -  -  0 
2000  -  -  -  -  -  -  -  -  -  -  -  0 
2001  -  -  -  -  -  -  -  -  -  -  -  0 
2002  -  -  -  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  -  -  -  0 
Total  1  0  0  0  0  0  0  0  0  0  0  1 
 
 Sample size healthy slaughter cattle BSE monitoring  
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Hungary (HU) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Hungary 
since 2004 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2004  2005  2006  2007  2008  2009  2010   2011 
1980  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  0 
1991  -  -  -  -  -  -  -  -  0 
1992  -  -  -  -  -  -  -  -  0 
1993  -  -  -  -  -  -  -  -  0 
1994  -  -  -  -  -  -  -  -  0 
1995  -  -  -  -  -  -  -  -  0 
1996  -  -  -  -  -  -  -  -  0 
1997  -  -  -  -  -  -  -  -  0 
1998  -  -  -  -  -  -  -  -  0 
1999  -  -  -  -  -  -  -  -  0 
2000  -  -  -  -  -  -  -  -  0 
2001  -  -  -  -  -  -  -  -  0 
2002  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  0 
Total  0  0  0  0  0  0  0  0  0 Sample size healthy slaughter cattle BSE monitoring  
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Ireland (IE) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Ireland 
since 2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  -  -  -  0 
1986  2  2  -  1  -  -  -  -  -  -  -  5 
1987  -  2  -  -  -  -  -  -  -  -  -  2 
1988  1  4  -  -  -  -  -  -  -  -  -  5 
1989  2  1  4  3  -  1  -  -  -  -  -  11 
1990  1  10  3  3  -  -  -  -  -  -  -  17 
1991  6  10  6  3  1  2  1  -  -  -  -  29 
1992  8  14  7  12  2  2  -  -  -  -  -  45 
1993  21  40  25  16  11  1  2  -  -  -  2  118 
1994  52  51  31  18  23  6  7  5  2  1  -  196 
1995  110  132  73  43  19  11  6  2  3  -  -  399 
1996  39  57  30  18  9  11  5  8  -  1  -  178 
1997  -  5  3  3  -  2  -  2  -  -  1  16 
1998  -  -  -  3  -  1  1  -  -  -  -  5 
1999  -  1  -  2  3  -  -  1  -  -  -  7 
2000  -  -  -  -  3  -  2  -  1  -  -  6 
2001  -  -  -  -  2  1  -  1  1  -  -  5 
2002  -  -  -  -  -  -  1  -  1  -  -  2 
2003  -  -  -  -  -  -  -  1  -  -  -  1 
2004  -  -  -  -  -  -  -  -  1  -  -  1 
2005  -  -  -  -  -  -  -  -  -  -  -  0 
Total  242  329  182  125  73  38  25  20  9  2  3  1 048 Sample size healthy slaughter cattle BSE monitoring  
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Italy (IT) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Italy since 
2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  -  -  -  0 
1987  1  -  -  -  -  -  -  -  -  -  -  1 
1988  -  -  2  -  -  -  -  -  -  -  -  2 
1989  -  -  -  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  -  -  -  0 
1991  -  1  -  -  -  -  -  -  -  -  -  1 
1992  -  -  1  -  1  1  1  -  -  -  -  4 
1993  1  -  3  -  -  -  -  -  -  -  -  4 
1994  8  5  1  -  -  -  -  -  -  -  -  14 
1995  12  10  4  -  -  -  -  1  -  -  -  27 
1996  20  14  10  4  3  1  -  -  1  -  -  53 
1997  8  4  9  2  1  1  1  -  -  -  1  27 
1998  -  2  1  -  -  -  -  -  1  -  -  4 
1999  -  -  -  1  2  2  -  -  -  -  -  5 
2000  -  -  -  -  1  1  -  -  -  -  -  2 
2001  -  -  -  -  -  1  -  -  -  -  -  1 
2002  -  -  -  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  -  -  -  0 
Total  50  36  31  7  8  7  2  1  2  0  1  145 Sample size healthy slaughter cattle BSE monitoring  
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Latvia (LV) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Latvia 
since 2004 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2004  2005  2006  2007  2008  2009  2010   2011 
1980  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  0 
1991  -  -  -  -  -  -  -  -  0 
1992  -  -  -  -  -  -  -  -  0 
1993  -  -  -  -  -  -  -  -  0 
1994  -  -  -  -  -  -  -  -  0 
1995  -  -  -  -  -  -  -  -  0 
1996  -  -  -  -  -  -  -  -  0 
1997  -  -  -  -  -  -  -  -  0 
1998  -  -  -  -  -  -  -  -  0 
1999  -  -  -  -  -  -  -  -  0 
2000  -  -  -  -  -  -  -  -  0 
2001  -  -  -  -  -  -  -  -  0 
2002  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  0 
Total  0  0  0  0  0  0  0  0  0 
 Sample size healthy slaughter cattle BSE monitoring  
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Lithuania (LT) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Lithuania 
since 2004 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2004  2005  2006  2007  2008  2009  2010   2011 
1980  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  0 
1991  -  -  -  -  -  -  -  -  0 
1992  -  -  -  -  -  -  -  -  0 
1993  -  -  -  -  -  -  -  -  0 
1994  -  -  -  -  -  -  -  -  0 
1995  -  -  -  -  -  -  -  -  0 
1996  -  -  -  -  -  -  -  -  0 
1997  -  -  -  -  -  -  -  -  0 
1998  -  -  -  -  -  -  -  -  0 
1999  -  -  -  -  -  -  -  -  0 
2000  -  -  -  -  -  -  -  -  0 
2001  -  -  -  -  -  -  -  -  0 
2002  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  0 
Total  0  0  0  0  0  0  0  0  0 
 
 Sample size healthy slaughter cattle BSE monitoring  
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Luxemburg (LU) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Luxemburg 
since 2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  -  -  -  0 
1991  -  -  -  -  -  -  -  -  -  -  -  0 
1992  -  -  -  -  -  -  -  -  -  -  -  0 
1993  -  -  -  -  -  -  -  -  -  -  -  0 
1994  -  -  -  -  -  -  -  -  -  -  -  0 
1995  -  -  -  -  -  -  -  -  -  -  -  0 
1996  -  1  -  -  -  -  -  -  -  -  -  1 
1997  -  -  -  -  -  -  -  -  -  -  -  0 
1998  -  -  -  -  -  -  -  -  -  -  -  0 
1999  -  -  -  -  -  -  -  -  -  -  -  0 
2000  -  -  -  -  -  -  -  -  -  -  -  0 
2001  -  -  -  -  1  -  -  -  -  -  -  1 
2002  -  -  -  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  -  -  -  0 
Total  0  1  0  0  1  0  0  0  0  0  0  2 
 
 Sample size healthy slaughter cattle BSE monitoring  
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Malta (MT) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Malta since 
2004 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2004  2005  2006  2007  2008  2009  2010   2011 
1980  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  0 
1991  -  -  -  -  -  -  -  -  0 
1992  -  -  -  -  -  -  -  -  0 
1993  -  -  -  -  -  -  -  -  0 
1994  -  -  -  -  -  -  -  -  0 
1995  -  -  -  -  -  -  -  -  0 
1996  -  -  -  -  -  -  -  -  0 
1997  -  -  -  -  -  -  -  -  0 
1998  -  -  -  -  -  -  -  -  0 
1999  -  -  -  -  -  -  -  -  0 
2000  -  -  -  -  -  -  -  -  0 
2001  -  -  -  -  -  -  -  -  0 
2002  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  0 
Total  0  0  0  0  0  0  0  0  0 
 Sample size healthy slaughter cattle BSE monitoring  
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Netherlands (NL) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in the 
Netherlands since 2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  -  -  -  0 
1988  1  -  -  -  -  -  -  -  -  -  -  1 
1989  -  -  -  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  -  -  -  0 
1991  -  -  1  1  -  -  -  -  -  -  -  2 
1992  1  1  -  -  -  -  -  -  -  -  -  2 
1993  2  1  -  -  -  -  -  -  -  -  -  3 
1994  2  2  -  -  -  -  -  -  -  -  -  4 
1995  4  3  -  -  -  -  -  -  -  -  -  7 
1996  9  10  10  3  -  -  -  -  -  1  -  33 
1997  1  4  5  1  -  1  -  -  -  1  -  13 
1998  -  3  1  1  -  1  -  -  -  -  -  6 
1999  -  -  1  -  -  -  1  -  -  1  -  3 
2000  -  -  -  -  2  -  1  1  -  -  -  4 
2001  -  -  -  -  1  -  -  -  -  -  -  1 
2002  -  -  -  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  -  -  -  0 
Total  20  24  18  6  3  2  2  1  0  3  0  79 Sample size healthy slaughter cattle BSE monitoring  
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Poland (PL) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Poland 
since 2004 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2004  2005  2006  2007  2008  2009  2010   2011 
1980  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  0 
1991  -  -  -  -  -  -  -  -  0 
1992  2  1  -  -  -  -  -  -  3 
1993  -  -  -  -  -  -  -  -  0 
1994  1  1  2  -  -  -  -  -  4 
1995  1  1  1  3  -  1  1  -  8 
1996  4  2  3  -  -  -  -  1  10 
1997  -  2  1  -  -  -  -  -  3 
1998  2  2  1  -  -  -  -  -  5 
1999  -  4  1  3  2  2  -  -  12 
2000  1  3  -  1  1  1  1  -  8 
2001  -  2  1  -  -  -  -  -  3 
2002  -  1  -  -  -  -  -  -  1 
2003  -  -  -  1  1  -  -  -  2 
2004  -  -  -  1  -  -  -  -  1 
2005  -  -  -  -  1  -  -  -  1 
Total  11  19  10  9  5  4  2  1  61 Sample size healthy slaughter cattle BSE monitoring  
 
EFSA Journal 2012;10(10):2913  84 
Portugal (PT) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Portugal 
since 2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  1  -  -  -  -  -  -  -  -  -  1 
1985  -  -  -  -  1  -  -  -  -  -  -  1 
1986  -  -  -  -  -  -  -  -  -  -  -  0 
1987  -  1  1  -  -  -  -  -  -  -  -  2 
1988  -  -  -  -  -  1  -  -  -  -  1  2 
1989  2  -  1  -  -  -  -  -  -  -  -  3 
1990  1  -  1  3  2  3  -  -  -  -  -  10 
1991  -  1  -  1  -  1  -  -  -  -  -  3 
1992  3  1  4  3  2  -  1  -  -  -  -  14 
1993  22  11  24  14  8  3  3  3  -  3  -  91 
1994  38  21  19  13  7  7  2  4  1  1  1  114 
1995  17  19  12  8  6  1  1  2  3  -  1  70 
1996  22  19  23  9  7  2  1  3  1  -  -  87 
1997  5  8  28  23  10  4  2  4  -  -  -  84 
1998  -  1  18  12  7  8  -  1  -  -  2  49 
1999  -  2  1  2  2  2  2  1  1  -  -  13 
2000  -  -  -  1  -  -  -  -  -  1  -  2 
2001  -  -  -  -  -  -  1  -  -  -  -  1 
2002  -  -  -  -  1  -  -  -  -  -  -  1 
2003  -  -  -  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  -  -  -  0 
Total  110  85  132  89  53  32  13  18  6  5  5  548 
 
 Sample size healthy slaughter cattle BSE monitoring  
 
EFSA Journal 2012;10(10):2913  85 
Slovakia (SK) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Slovakia 
since 2004 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2004  2005  2006  2007  2008  2009  2010   2011 
1980  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  0 
1991  -  -  -  -  -  -  -  -  0 
1992  -  -  -  -  -  -  -  -  0 
1993  -  -  -  -  -  -  -  -  0 
1994  -  -  -  -  -  -  -  -  0 
1995  2  -  -  -  -  -  -  -  2 
1996  -  -  -  -  -  -  -  -  0 
1997  -  -  -  -  -  -  -  -  0 
1998  -  -  -  -  -  -  -  -  0 
1999  1  -  -  -  -  -  -  -  1 
2000  2  2  -  -  -  -  -  -  4 
2001  2  -  -  2  1  -  -  -  5 
2002  -  -  -  -  -  -  1  -  1 
2003  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  0 
Total  7  2  0  2  1  0  1  0  13 
 Sample size healthy slaughter cattle BSE monitoring  
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Slovenia (SI) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Slovenia 
since 2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  -  -  -  0 
1991  -  -  -  -  -  -  -  -  -  -  -  0 
1992  -  -  -  -  -  -  -  -  -  -  -  0 
1993  -  -  -  -  -  -  -  -  -  -  -  0 
1994  -  -  -  -  -  -  -  -  -  -  -  0 
1995  -  1  -  -  -  -  -  -  -  -  -  1 
1996  1  -  -  -  -  -  -  -  -  -  -  1 
1997  -  -  -  -  -  -  -  -  -  -  -  0 
1998  -  -  -  1  -  -  -  -  -  -  -  1 
1999  -  -  1  -  -  -  -  -  -  -  -  1 
2000  -  -  -  1  1  1  1  -  -  -  -  4 
2001  -  -  -  -  -  -  -  -  -  -  -  0 
2002  -  -  -  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  -  -  -  0 
Total  1  1  1  2  1  1  1  0  0  0  0  8 
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Spain (ES) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Spain since 
2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  -  -  -  0 
1986  1  -  -  -  -  -  -  -  -  -  -  1 
1987  1  -  1  -  -  -  -  -  -  -  -  2 
1988  1  1  1  -  -  -  -  -  -  -  -  3 
1989  1  2  1  -  -  -  1  -  1  -  -  6 
1990  1  -  1  1  -  -  -  1  1  -  -  5 
1991  -  -  -  -  -  -  -  -  -  -  1  1 
1992  1  1  2  1  -  -  1  1  -  -  -  7 
1993  10  12  6  5  1  1  1  -  2  -  -  38 
1994  13  9  9  4  3  1  -  1  1  -  -  41 
1995  22  33  24  9  2  1  3  1  1  2  1  99 
1996  20  33  34  14  7  4  1  2  -  2  -  117 
1997  11  28  56  30  13  10  1  3  2  1  1  156 
1998  -  7  26  49  22  18  7  4  3  1  1  138 
1999  -  1  4  19  23  17  6  4  3  4  -  81 
2000  -  -  1  5  26  23  11  3  4  2  2  77 
2001  -  -  -  -  -  1  -  3  -  -  -  4 
2002  -  -  -  -  1  -  -  1  -  -  -  2 
2003  -  -  -  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  -  1  -  1 
2005  -  -  -  -  -  -  -  -  -  -  1  1 
Total  82  127  166  137  98  76  32  24  18  13  7  780 
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Sweden (SE) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in Sweden 
since 2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  -  -  -  -  -  -  -  -  -  -  0 
1981  -  -  -  -  -  -  -  -  -  -  -  0 
1982  -  -  -  -  -  -  -  -  -  -  -  0 
1983  -  -  -  -  -  -  -  -  -  -  -  0 
1984  -  -  -  -  -  -  -  -  -  -  -  0 
1985  -  -  -  -  -  -  -  -  -  -  -  0 
1986  -  -  -  -  -  -  -  -  -  -  -  0 
1987  -  -  -  -  -  -  -  -  -  -  -  0 
1988  -  -  -  -  -  -  -  -  -  -  -  0 
1989  -  -  -  -  -  -  -  -  -  -  -  0 
1990  -  -  -  -  -  -  -  -  -  -  -  0 
1991  -  -  -  -  -  -  -  -  -  -  -  0 
1992  -  -  -  -  -  -  -  -  -  -  -  0 
1993  -  -  -  -  -  -  -  -  -  -  -  0 
1994  -  -  -  -  -  1  -  -  -  -  -  1 
1995  -  -  -  -  -  -  -  -  -  -  -  0 
1996  -  -  -  -  -  -  -  -  -  -  -  0 
1997  -  -  -  -  -  -  -  -  -  -  -  0 
1998  -  -  -  -  -  -  -  -  -  -  -  0 
1999  -  -  -  -  -  -  -  -  -  -  -  0 
2000  -  -  -  -  -  -  -  -  -  -  -  0 
2001  -  -  -  -  -  -  -  -  -  -  -  0 
2002  -  -  -  -  -  -  -  -  -  -  -  0 
2003  -  -  -  -  -  -  -  -  -  -  -  0 
2004  -  -  -  -  -  -  -  -  -  -  -  0 
2005  -  -  -  -  -  -  -  -  -  -  -  0 
Total  0  0  0  0  0  1  0  0  0  0  0  1 
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United Kingdom (UK) 
 
Number of BSE cases detected through the BSE Surveillance (Active and Passive) in United 
Kingdom since 2001 per birth cohort and year of detection. 
 
Birth cohort 
N° of detected BSE cases per year 
Total  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 
1980  -  1  -  -  -  -  -  -  -  -  -  1 
1981  1  -  -  -  -  -  -  -  -  1  -  2 
1982  -  -  -  -  -  -  -  -  -  -  -   
1983  -  -  1  -  -  -  -  -  -  -  -  1 
1984  1  2  -  -  -  1  -  -  -  -  -  4 
1985  1  2  2  -  -  -  -  -  -  -  -  5 
1986  10  8  3  1  1  -  -  -  -  -  -  23 
1987  19  26  6  6  6  1  -  1  -  -  -  65 
1988  17  22  18  8  -  -  -  2  -  -  -  67 
1989  20  34  14  14  5  4  -  1  -  -  -  92 
1990  24  42  16  14  6  4  1  1  -  -  -  108 
1991  58  63  37  21  20  5  -  1  -  1  -  206 
1992  104  130  68  37  29  12  7  -  1  -  1  389 
1993  241  160  115  56  33  20  11  4  2  1  -  643 
1994  362  303  133  73  51  30  16  6  2  1  2  979 
1995  310  275  136  65  31  23  9  4  1  1  -  855 
1996  25  37  24  10  5  7  -  8  -  1  1  118 
1997  9  13  18  4  4  3  1  3  1  1  1  58 
1998  1  4  14  11  6  3  7  2  -  1  1  50 
1999  -  1  5  6  11  4  3  3  -  -  1  34 
2000  -  -  -  2  4  4  3  -  -  1  1  15 
2001  -  -  -  -  1  4  1  1  -  -  -  7 
2002  -  -  -  -  -  1  2  2  1  -  -  6 
2003  -  -  -  -  -  -  -  2  3  -  -  5 
2004  -  -  -  -  -  -  -  -  -  2  -  2 
2005  -  -  -  -  -  -  -  -  -  -  -    
Total  1 203  1 123  610  328  213  126  61  41  11  11  8  3735 
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ABBREVIATIONS 
EU25   The  group  of  following  EU  MSs:  Austria,  Belgium,  Czech  Republic,  Cyprus, 
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, 
Lithuania,  Luxembourg,  Malta,  Netherlands,  Poland,  Portugal,  Slovenia,  Slovakia, 
Spain, Sweden and United Kingdom. 
EU17  The  group  of  following  EU  MSs:  Austria,  Belgium,  Cyprus,  Denmark,  Finland, 
France,  Germany,  Greece,  Ireland,  Italy,  Luxembourg,  Netherlands,  Portugal, 
Slovenia, Spain, Sweden and United Kingdom. 
EU8  The  group  of  following  EU  MSs:  Czech  Republic,  Estonia,  Hungary,  Latvia, 
Lithuania, Malta, Poland and Slovakia. 
EU5    The group of following EU MSs: Estonia, Hungary, Latvia, Lithuania and Malta. 
EU3    The group of following EU MSs: Czech Republic, Poland and Slovakia. 
C-BSE    Classical BSE 
C-TSEMM  Cattle TSE Monitoring Model 
H-BSE   H-type BSE 
L-BSE    L-type BSE 
MS/MSs   Member State/Member States of the European Union 
PrP
res  The PK resistant core of the the N-terminally truncated form of abnormal disease-
associated  isoforms  (PrP
Sc)  of  the  normal  cellular  prion  protein  (PrP
C),  following 
digestion with proteinase K in the presence of detergents.  
 
 
 
 
 
 
 
 
 